CN114317561A - Broccoli gene fixed-point editing method based on CRISPR/Cas9 - Google Patents
Broccoli gene fixed-point editing method based on CRISPR/Cas9 Download PDFInfo
- Publication number
- CN114317561A CN114317561A CN202210155687.0A CN202210155687A CN114317561A CN 114317561 A CN114317561 A CN 114317561A CN 202210155687 A CN202210155687 A CN 202210155687A CN 114317561 A CN114317561 A CN 114317561A
- Authority
- CN
- China
- Prior art keywords
- plasmid
- dna fragment
- expression frame
- linearized
- target site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091033409 CRISPR Proteins 0.000 title claims abstract description 92
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 title claims abstract description 70
- 235000017647 Brassica oleracea var italica Nutrition 0.000 title claims abstract description 66
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 61
- 238000000034 method Methods 0.000 title claims abstract description 41
- 238000010354 CRISPR gene editing Methods 0.000 title claims abstract description 16
- 244000308180 Brassica oleracea var. italica Species 0.000 title 1
- 108091027544 Subgenomic mRNA Proteins 0.000 claims abstract description 92
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims abstract description 73
- 239000013604 expression vector Substances 0.000 claims abstract description 37
- 241000196324 Embryophyta Species 0.000 claims abstract description 22
- 241000589158 Agrobacterium Species 0.000 claims abstract description 11
- 239000012634 fragment Substances 0.000 claims description 177
- 239000013612 plasmid Substances 0.000 claims description 177
- 108091036060 Linker DNA Proteins 0.000 claims description 70
- 108020004414 DNA Proteins 0.000 claims description 69
- 102000012410 DNA Ligases Human genes 0.000 claims description 69
- 108010061982 DNA Ligases Proteins 0.000 claims description 69
- 238000006243 chemical reaction Methods 0.000 claims description 54
- 238000001976 enzyme digestion Methods 0.000 claims description 54
- 230000000295 complement effect Effects 0.000 claims description 20
- 238000012216 screening Methods 0.000 claims description 19
- 108010042407 Endonucleases Proteins 0.000 claims description 17
- 102000004533 Endonucleases Human genes 0.000 claims description 17
- 102000004190 Enzymes Human genes 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 17
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 claims description 17
- 239000007787 solid Substances 0.000 claims description 17
- 239000001963 growth medium Substances 0.000 claims description 16
- 229930027917 kanamycin Natural products 0.000 claims description 16
- 229960000318 kanamycin Drugs 0.000 claims description 16
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 16
- 229930182823 kanamycin A Natural products 0.000 claims description 16
- 238000003752 polymerase chain reaction Methods 0.000 claims description 16
- 230000001131 transforming effect Effects 0.000 claims description 16
- 230000009471 action Effects 0.000 claims description 15
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 15
- 238000012258 culturing Methods 0.000 claims description 14
- 239000000499 gel Substances 0.000 claims description 14
- 108091008146 restriction endonucleases Proteins 0.000 claims description 14
- 239000011248 coating agent Substances 0.000 claims description 13
- 238000000576 coating method Methods 0.000 claims description 13
- 238000001816 cooling Methods 0.000 claims description 12
- 230000029087 digestion Effects 0.000 claims description 11
- 230000009261 transgenic effect Effects 0.000 claims description 10
- 239000002609 medium Substances 0.000 claims description 8
- 230000003321 amplification Effects 0.000 claims description 6
- 238000004458 analytical method Methods 0.000 claims description 6
- 238000004925 denaturation Methods 0.000 claims description 6
- 230000036425 denaturation Effects 0.000 claims description 6
- 238000007865 diluting Methods 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 108010042546 GCGGCCGC-specific type II deoxyribonucleases Proteins 0.000 claims description 4
- 101150019315 101 gene Proteins 0.000 claims description 3
- 238000012268 genome sequencing Methods 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- 238000009395 breeding Methods 0.000 abstract description 12
- 230000001488 breeding effect Effects 0.000 abstract description 11
- 238000011160 research Methods 0.000 abstract description 9
- 238000005516 engineering process Methods 0.000 abstract description 8
- 238000001514 detection method Methods 0.000 abstract description 6
- 230000006872 improvement Effects 0.000 abstract description 6
- 208000035240 Disease Resistance Diseases 0.000 abstract description 4
- 230000009466 transformation Effects 0.000 abstract description 4
- 238000010362 genome editing Methods 0.000 abstract description 3
- 230000001404 mediated effect Effects 0.000 abstract description 3
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 26
- 238000012163 sequencing technique Methods 0.000 description 6
- 238000012217 deletion Methods 0.000 description 5
- 230000037430 deletion Effects 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000219198 Brassica Species 0.000 description 3
- 238000010453 CRISPR/Cas method Methods 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 101100022430 Arabidopsis thaliana MYB101 gene Proteins 0.000 description 2
- 101100403691 Arabidopsis thaliana MYB120 gene Proteins 0.000 description 2
- 101100185995 Arabidopsis thaliana MYB97 gene Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 229930182475 S-glycoside Natural products 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 2
- 150000003569 thioglycosides Chemical class 0.000 description 2
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000011302 Brassica oleracea Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- IVYPNXXAYMYVSP-UHFFFAOYSA-N Indole-3-carbinol Natural products C1=CC=C2C(CO)=CNC2=C1 IVYPNXXAYMYVSP-UHFFFAOYSA-N 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- 101150054012 MYB101 gene Proteins 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000019827 double fertilization forming a zygote and endosperm Effects 0.000 description 1
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 235000002279 indole-3-carbinol Nutrition 0.000 description 1
- RUMVKBSXRDGBGO-UHFFFAOYSA-N indole-3-carbinol Chemical compound C1=CC=C[C]2C(CO)=CN=C21 RUMVKBSXRDGBGO-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012883 rooting culture medium Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000015487 sulforaphane Nutrition 0.000 description 1
- 229960005559 sulforaphane Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a broccoli gene fixed-point editing method based on CRISPR/Cas9, and relates to the technical field of genetic engineering. According to the method provided by the invention, the broccoli BoMYB101 gene is subjected to site-specific knockout editing by using a CRISPR/Cas9 technology, 2 sgRNA target sites are designed according to a broccoli BoMYB101 gene sequence, a knockout expression vector of the BoMYB101 gene is constructed, the cauliflower hypocotyl is subjected to agrobacterium-mediated transformation, and a mutant plant is screened by molecular detection, so that a high-efficiency broccoli gene editing plant is obtained, and an application support is provided for character improvement and gene function research of the broccoli plant such as disease resistance, cold resistance, breeding and the like.
Description
Technical Field
The invention relates to the technical field of genetic engineering, in particular to a broccoli gene fixed-point editing method based on CRISPR/Cas 9.
Background
Broccoli (A. B. Moench)Brassica oleracea L. var. iTalica) also known as broccoli, the Mediterranean region of origin. Broccoli is a variety of brassica species in brassica of brassicaceae and is known as "vegetable crown" due to abundant nutrition. Also rich in thioglycoside and having anticancer effect, and particularly, the anticancer mechanism of the metabolic component of the component, namely, the mustard (indole-3-carbinol), has been scientifically demonstrated from the molecular level. The broccoli is also rich in the linear thioglycoside sulforaphane, so that the low-fat-density cholesterol can be effectively reduced, the incidence rate of heart diseases is reduced, and the broccoli is popular with consumers at home and abroad. The broccoli is one of the important large vegetable varieties in China, is planted all over the country, is mainly concentrated in the places of Yunnan, Hebei, Zhejiang, Hubei, Jiangsu, Guangdong and the like, and the planting area is more than 8.7 million hectares (130 million mu). Broccoli is also an important export-earning vegetable, and the annual export amount exceeds 12 million tons.
The back of the dominant industry of broccoli in China is the weak breeding industry, the core breeding industry mainly depends on import from Japan and other countries, the foreign variety occupancy once exceeds 95%, and the monopoly is formed for the broccoli seed supply in China. The research and breeding of broccoli in China are late, the excellent resources are lack, the existing excellent resources can not be reused due to the wide use of the male sterility technology, and the research and breeding of broccoli in China are still different from those of international enterprises and research institutions. The molecular breeding development of broccoli is very lagged because the restriction genetic transformation system such as the characteristics, the genotype and the like of broccoli materials is difficult to establish all the time.
Disclosure of Invention
The invention mainly aims to provide a broccoli gene fixed-point editing method based on CRISPR/Cas9, which is used for solving the technical problem of poor comprehensive properties of broccoli plants such as disease resistance, cold resistance, breeding and the like in the prior art, thereby achieving the technical effect of improving the comprehensive properties of broccoli varieties. The technical scheme of the invention is as follows:
according to an aspect of the embodiment of the invention, a method for fixed-point editing of broccoli genes based on CRISPR/Cas9 is provided, which is characterized by comprising the following steps:
obtaining a BoMYB101 gene sequence according to broccoli inbred line 2M genome sequencing analysis, selecting 5'-GCCAAATCTAAGGACAGGAT-3' sequence as a target site sgT1 from a first exon of the BoMYB101 gene sequence, selecting 5'-GATTCACCTGCGGGGAACAG-3' sequence as a target site sgT2 from a second exon of the BoMYB101 gene sequence, and respectively synthesizing complementary primer pairs corresponding to the target sites, wherein the complementary primer pairs corresponding to the target sites sgT1 comprise:
sgT1-F:5’-TGCAGCCAAATCTAAGGACAGGAT-3’、sgT1-R:5’-AAACATCCTGTCCTTAGATTTGGC-3’;
the complementary primer pair corresponding to target site sgT2 includes:
sgT2-F:5’-TGCAGATTCACCTGCGGGGAACAG-3’、sgT2-R:5’-AAACCTGTTCCCCGCAGGTGAATC-3’;
for each complementary primer pair, according to primer F and primer R, ddH2Preparing a reaction system of the complementary primer pair with the volume ratio of O being 1:1:8, carrying out 95 ℃ denaturation on the reaction system of the complementary primer pair for 5min by using a PCR (polymerase chain reaction) amplification instrument, then cooling to 25 ℃ at the cooling rate of 0.2 ℃/s, and using ddH (ddH) to react products2Diluting by 250 times through O to obtain DNA fragments of each target site, wherein the concentrations of the primer F and the primer R are both 100 mu Mol/L;
connecting each target site DNA fragment to a sgRNA expression frame respectively to construct a sgRNA expression frame plasmid containing two target site DNA fragments;
according to the primer FW and the primers RV and ddH2Preparing a reaction system of a linker primer pair with the volume ratio of O being 1:1:8, carrying out denaturation on the reaction system of the linker primer pair for 5min at 95 ℃ by using a PCR (polymerase chain reaction) amplification instrument, then cooling to 25 ℃ at the cooling rate of 0.2 ℃/s, and using ddH (ddH) to react products2Diluting by 250 times through O to obtain a linker DNA fragment, wherein the concentration of the primer FW and the concentration of the primer RV are both 100 mu Mol/L, and the linker primer pair comprises:
FW:5’-CGTACCTGCAGGAAAGCGGCCGCGTCAGGCGCGCCTAACT-3’、RV:5’-CTAGAGTTAGGCGCGCCTGACGCGGCCGCTTTCCTGCAGGTACGAGCT-3’;
the linker DNA fragment was ligated to the expression vector pCAMBIA2301 plasmidSacI andXbaconstructing pCAMBIA2301 plasmid containing linker DNA fragment between enzyme cutting sites I;
using restriction endonucleasesNotI andAsci, connecting Cas9 expression frame to pCAMBIA2301 plasmid containing linker DNA fragmentNotI andAscobtaining pCAMBIA2301 plasmid containing linker DNA fragment and Cas9 expression frame between enzyme cutting sites;
using restriction endonucleasesNotI andSbfi, connecting the sgRNA expression frame plasmid containing the DNA fragments with the two target sites to the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frameNotI andSbfi, obtaining an expression vector plasmid edited by a BoMYB101 gene between enzyme cutting sites;
transforming the expression vector plasmid edited by the BoMYB101 gene into an EHA105 agrobacterium-competent cell by using a freeze-thaw method to obtain an EHA105 agrobacterium strain containing the expression vector plasmid;
and infecting the broccoli hypocotyl explant by the EHA105 agrobacterium strain containing the expression vector plasmid, and obtaining a transgenic plant of which the expression vector is introduced into broccoli cells through resistance screening culture.
Preferably, the step of constructing a sgRNA expression frame plasmid containing two target site DNA fragments by separately ligating each target site sequence fragment into a sgRNA expression frame includes:
according to the expression frame plasmid of 10 XNEB Buffer 2.1 and sgRNA and endonucleaseBsaⅠ、ddH2Preparing a sgRNA expression frame enzyme digestion reaction system corresponding to sgT1 target sites with the volume ratio of O being 3:4:1:22, and using the endonuclease of type II endonuclease site for the sgRNA expression frame plasmidBsaI, enzyme digestion, carrying out agarose gel electrophoresis on the enzyme digestion product, cutting the gel and recycling to obtain the productBsaI, digesting a linearized sgRNA expression frame plasmid;
according toBsaI, preparing a sgT1 target site assembly and connection reaction system by carrying out enzyme digestion on a linearized sgRNA expression cassette plasmid, an sgT1 target site DNA fragment, a T4 DNA ligase Buffer and a T4 DNA ligase in a volume ratio of 15:2:2:1, and carrying out enzyme digestion on the sgRNA expression cassette plasmid and the DNA fragment of the target site sgT1BsaI, connecting the linearized sgRNA expression frame plasmid subjected to enzyme digestion at 4 ℃ overnight under the action of T4 DNA ligase Buffer and T4 DNA ligase, then transforming a connecting product into an escherichia coli DH5 alpha competent cell, coating the competent cell on an LB solid culture medium with 50 mu g/mL kanamycin, culturing at 37 ℃ overnight, screening positive clones, and extracting to obtain a sgRNA expression frame plasmid containing a sgT1 target site DNA fragment;
10 XNEB Buffer 2.1, sgRNA expression frame plasmid containing sgT1 target site DNA fragment and endonucleaseBbsⅠ、ddH2Preparing a sgRNA expression frame enzyme digestion reaction system corresponding to sgT2 target sites with the volume ratio of O being 3:4:1:22, and carrying out endonuclease treatment on the sgRNA expression frame plasmid containing the DNA fragment with the sgT1 target sites by using type II endonuclease sitesBbsI, enzyme digestion, carrying out agarose gel electrophoresis on the enzyme digestion product, cutting the gel and recycling to obtain the productBbsI, digesting a linearized sgRNA expression frame plasmid;
according toBbsI, preparing a sgT2 target site assembly and connection reaction system by carrying out enzyme digestion on a linearized sgRNA expression cassette plasmid, an sgT2 target site DNA fragment, a T4 DNA ligase Buffer and a T4 DNA ligase in a volume ratio of 15:2:2:1, and carrying out enzyme digestion on the sgRNA expression cassette plasmid and the DNA fragment of the target site sgT2BbsI after enzyme digestion, linearized sgRNA expression frame plasmids are connected at 4 ℃ overnight under the action of T4 DNA ligase Buffer and T4 DNA ligase, then the connection products are transformed into escherichia coli DH5 alpha competent cells, the competent cells are coated on LB solid culture medium with 50 mu g/mL kanamycin and cultured at 37 ℃ overnight, and positive grams are screenedAnd (4) extracting to obtain sgRNA expression frame plasmids containing two target site DNA fragments.
Preferably, the linker DNA fragment is ligated to the expression vector pCAMBIA2301 plasmidSacI andXbathe method comprises the following steps of constructing pCAMBIA2301 plasmid containing linker DNA fragment between enzyme cutting sites, wherein the pCAMBIA2301 plasmid comprises the following steps:
according to the method, 10 XNEB Buffer, pCAMBIA2301 plasmid and restriction enzymeSacI, restriction enzymeXbaⅠ、ddH2Preparing a first pCAMBIA2301 linear enzyme digestion reaction system with the volume ratio of O being 5:5:1:1:38, and using restriction enzyme for pCAMBIA2301 plasmidSacI andXbacarrying out double digestion, carrying out agarose gel electrophoresis on a digestion product, cutting gel, and recovering a linearized pCAMBIA2301 plasmid;
preparing a Linker DNA fragment connection reaction system according to the volume ratio of the Linker DNA fragment to the linearized pCAMBIA2301 plasmid, T4 DNA ligase Buffer and T4 DNA ligase of 6:20:3:1, connecting the Linker DNA fragment and the linearized pCAMBIA2301 plasmid at 4 ℃ under the action of T4 DNA ligase Buffer and T4 DNA ligase overnight, transforming a connection product into an Escherichia coli DH5 alpha competent cell, coating the Escherichia coli DH5 alpha competent cell on an LB solid culture medium with 50 mu g/mL kanamycin, culturing at 37 ℃ overnight, screening positive clones, and extracting to obtain the pCAMBIA2301 plasmid containing the Linker DNA fragment.
Preferably, the use of restriction enzymesNotI andAsci, connecting Cas9 expression frame to pCAMBIA2301 plasmid containing linker DNA fragmentNotI andAscthe method comprises the following steps of I, obtaining pCAMBIA2301 plasmid containing linker DNA fragment and Cas9 expression frame between enzyme cutting sites, wherein the pCAMBIA2301 plasmid comprises the following steps:
according to the method, 10 XNEB Buffer is mixed with pCAMBIA2301 plasmid containing linker DNA fragment and restriction enzymeNotI, restriction enzymeAscⅠ、ddH2Preparing a second pCAMBIA2301 linear enzyme digestion reaction system with the volume ratio of O to 5:5:1:1:38, and utilizing restriction enzymeNotI andAscthe pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frame are subjected to double enzyme digestion simultaneously, and the enzyme digestion product is subjected to agarose gel electrophoresis, gel cutting, recovery and linearization, and containspCAMBIA2301 plasmid with linker DNA fragment and linearized Cas9 expression cassette fragment;
preparing a Cas9 expression frame fragment connection reaction system according to the volume ratio of a linearized Cas9 expression frame fragment to the linearized pCAMBIA2301 plasmid containing the linker DNA fragment, T4 DNA ligase Buffer and T4 DNA ligase being 6:20:3:1, connecting the linearized pCAMBIA2301 plasmid containing the linker DNA fragment and the linearized Cas9 expression frame fragment at the action of T4 DNA ligase Buffer and T4 DNA ligase at 4 ℃ overnight, transforming a connection product into Escherichia coli DH5 alpha competent cells, coating the cells on LB solid medium with 50 mu g/mL kanamycin at 37 ℃ for overnight, screening positive clones, and extracting the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frame.
Preferably, the use of restriction enzymesNotI andSbfi, connecting the sgRNA expression frame plasmid containing the DNA fragments with the two target sites to the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frameNotI andSbfthe method comprises the following steps of I, obtaining an expression vector plasmid edited by a BoMYB101 gene between enzyme cutting sites, wherein the steps comprise:
mixing 10 XNEB Buffer with pCAMBIA2301 plasmid containing linker DNA fragment and Cas9 expression cassette, restriction endonucleaseNotI, restriction enzymeSbfⅠ、ddH2Preparing a third pCAMBIA2301 linear enzyme digestion reaction system with the volume ratio of O to 5:5:1:1:38, and utilizing restriction enzymeNotI andSbfcarrying out double enzyme digestion on the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frame and the sgRNA expression frame plasmid containing the two target site DNA fragments, carrying out agarose gel electrophoresis on the digestion products, cutting gel, and recovering a linearized pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frame and a linearized sgRNA expression frame fragment containing the two target site DNA fragments;
preparing a sgRNA expression frame fragment connection reaction system according to the volume ratio of the sgRNA expression frame fragment which is linearized and contains two target site DNA fragments to the pCAMBIA2301 plasmid which is linearized and contains a linker DNA fragment and a Cas9 expression frame, the T4 DNA ligase Buffer and the T4 DNA ligase are 6:20:3:1, connecting the sgRNA expression frame fragment which is linearized and contains two target site DNA fragments and the pCAMBIA2301 plasmid which is linearized and contains the linker DNA fragment and the Cas9 expression frame at the action of the T4 DNA ligase Buffer and the T4 DNA ligase at 4 ℃ overnight, transforming a connecting product into Escherichia coli 5 alpha competent cells, coating the cells on LB solid medium with 50 mu g/mL of kanamycin, culturing at 37 ℃ overnight, screening positive clones, and extracting expression vector plasmids edited by the BoB 101 gene.
Preferably, the efficiency of editing the BoMYB101 gene by the expression vector plasmid is 75-80%.
Compared with the prior art, the broccoli gene site-directed editing method based on CRISPR/Cas9 provided by the invention has the following advantages:
the invention provides a CRISPR/Cas 9-based broccoli gene site-directed editing method, which is characterized in that a CRISPR/Cas9 technology is utilized to perform site-directed knockout editing on a broccoli BoMYB101 gene, 2 sgRNA target sites are designed according to a broccoli BoMYB101 gene sequence, a knockout expression vector of the BoMYB101 gene is constructed, a cauliflower hypocotyl is subjected to agrobacterium-mediated transformation, and a mutant plant is screened by molecular detection, so that a high-efficiency broccoli gene editing plant is obtained, and application support is provided for character improvement and gene function research of disease resistance, cold resistance, breeding and the like of the broccoli plant.
Drawings
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments consistent with the invention and together with the description, serve to explain the principles of the invention.
FIG. 1 is a schematic diagram of an expression vector plasmid edited by a BoMYB101 gene provided by the invention.
FIG. 2 is a schematic diagram of the transgene detection of broccoli provided by the present invention.
FIG. 3 is a direct sequencing peak diagram of a PCR product of a target site of a broccoli BoMYB101 gene provided by the invention.
FIG. 4 is a statistical chart of monoclonal sequencing analysis of broccoli BoMYB101 gene target site sgT2 provided by the invention.
Detailed Description
In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings needed to be used in the description of the embodiments will be briefly introduced below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art to obtain other drawings based on these drawings without creative efforts.
The genotype of broccoli determines that the broccoli has great difficulty in character improvement and molecular biology research, and in order to avoid the technical problems, the inventor provides a method for editing a broccoli gene at a fixed point based on CRISPR/Cas9 through a large amount of creative experimental research and thinking, which is specifically shown as follows.
A method for fixed-point editing of broccoli genes based on CRISPR/Cas9, comprising:
a step (100): obtaining a BoMYB101 gene sequence according to broccoli inbred line 2M genome sequencing analysis, selecting 5'-GCCAAATCTAAGGACAGGAT-3' sequence as a target site sgT1 from a first exon of the BoMYB101 gene sequence, selecting 5'-GATTCACCTGCGGGGAACAG-3' sequence as a target site sgT2 from a second exon of the BoMYB101 gene sequence, and respectively synthesizing complementary primer pairs corresponding to the target sites, wherein the complementary primer pairs corresponding to the target sites sgT1 comprise:
sgT1-F:5’-TGCAGCCAAATCTAAGGACAGGAT-3’、sgT1-R:5’-AAACATCCTGTCCTTAGATTTGGC-3’;
the complementary primer pair corresponding to target site sgT2 includes:
sgT2-F:5’-TGCAGATTCACCTGCGGGGAACAG-3’、sgT2-R:5’-AAACCTGTTCCCCGCAGGTGAATC-3’。
it should be noted that MYB97, MYB101 and MYB120, which are pollen transcription factors, may participate in information exchange between a pollen tube and a helper cell through the expression of transcription regulation downstream genes, and a MYB97, MYB101 and MYB120 ternary mutant pollen tube cannot stop growing after entering a embryo sac, cannot burst to release sperm cells, and cannot perform double fertilization, so that the study on the MYB101 gene function is important for analyzing the molecular mechanism accepted by the pollen tube.
Step (200): for each complementary primer pair, according to primer F and primer R, ddH2Preparing a reaction system of the complementary primer pair with the volume ratio of O being 1:1:8, carrying out 95 ℃ denaturation on the reaction system of the complementary primer pair for 5min by using a PCR (polymerase chain reaction) amplification instrument, then cooling to 25 ℃ at the cooling rate of 0.2 ℃/s, and using ddH (ddH) to react products2Diluting by 250 times through O to obtain DNA fragments of each target site, wherein the concentration of the primer F and the concentration of the primer R are both 100 mu Mol/L.
In one possible embodiment, the reaction system of the complementary primer pair has primer F and primer R, ddH2The volume of O was 1. mu.L, and 8. mu.L, respectively.
Step (300): and respectively connecting the DNA fragments of the target sites to the sgRNA expression frame to construct a sgRNA expression frame plasmid containing the DNA fragments of the two target sites.
Preferably, the step of constructing a sgRNA expression frame plasmid containing two target site DNA fragments by separately ligating each target site sequence fragment into a sgRNA expression frame includes:
step (310): 10 XNEB Buffer 2.1 and sgRNA expression frame plasmid, endonuclease BsaI, ddH2Preparing a sgRNA expression frame enzyme digestion reaction system corresponding to sgT1 target sites with the volume ratio of O being 3:4:1:22, and using the endonuclease of type II endonuclease site for the sgRNA expression frame plasmidBsaI, enzyme digestion, carrying out agarose gel electrophoresis on the enzyme digestion product, cutting the gel and recycling to obtain the productBsaI restriction enzyme digestion of linearized sgRNA expression frame plasmid.
In one possible embodiment, the expression frame plasmid of 10 XNEB Buffer 2.1 and sgRNA and the endonuclease in the sgRNA expression frame enzyme digestion reaction system corresponding to the sgT1 target siteBsaⅠ、ddH2The volumes of O were 3. mu.L, 4. mu.L, 22. mu.L, and 1. mu.L, respectively.
A step (320): preparing a sgT1 target site assembly and connection reaction system according to the volume ratio of the linearized sgRNA expression frame plasmid after Bsa I digestion to the sgT1 target site DNA fragment, the T4 DNA ligase Buffer and the T4 DNA ligase of 15:2:2:1, and mixing the sgT1 target site DNA fragment and the DNA fragment of the sgT1 target siteBsaI the linearized sgRNA expression cassette plasmid after digestion is linked at 4 ℃ under the action of T4 DNA ligase Buffer and T4 DNA ligaseInoculating overnight, then transforming the ligation product into escherichia coli DH5 alpha competent cells, coating the cells on LB solid culture medium with 50 ug/mL kanamycin, culturing overnight at 37 ℃, screening positive clones, and extracting sgRNA expression frame plasmid containing sgT1 target site DNA fragment.
In one possible embodiment, sgT1 target site assembly is connected in the reaction systemBsaThe volumes of the linearized sgRNA expression cassette plasmid after digestion, sgT1 target site DNA fragment, T4 DNA ligase Buffer and T4 DNA ligase are 15 muL, 2 muL, 22 muL and 1 muL respectively.
Step (330): 10 XNEB Buffer 2.1, sgRNA expression frame plasmid containing sgT1 target site DNA fragment and endonucleaseBbsⅠ、ddH2Preparing a sgRNA expression frame enzyme digestion reaction system corresponding to sgT2 target sites with the volume ratio of O being 3:4:1:22, and carrying out endonuclease treatment on the sgRNA expression frame plasmid containing the DNA fragment with the sgT1 target sites by using type II endonuclease sitesBbsI, enzyme digestion, carrying out agarose gel electrophoresis on the enzyme digestion product, cutting the gel and recycling to obtain the productBbsI restriction enzyme digestion of linearized sgRNA expression frame plasmid.
In one possible embodiment, 10 XNEB Buffer 2.1 and sgRNA expression frame plasmid containing sgT1 target site DNA fragment and endonuclease in sgRNA expression frame enzyme digestion reaction system corresponding to sgT2 target siteBbsⅠ、ddH2The volumes of O were 3. mu.L, 4. mu.L, 1. mu.L, and 22. mu.L, respectively.
Step (340): according toBbsI, preparing a sgT2 target site assembly and connection reaction system by carrying out enzyme digestion on a linearized sgRNA expression cassette plasmid, an sgT2 target site DNA fragment, a T4 DNA ligase Buffer and a T4 DNA ligase in a volume ratio of 15:2:2:1, and carrying out enzyme digestion on the sgRNA expression cassette plasmid and the DNA fragment of the target site sgT2BbsI after enzyme digestion, linearized sgRNA expression frame plasmids are connected at 4 ℃ overnight under the action of T4 DNA ligase Buffer and T4 DNA ligase, then a connection product is transformed into escherichia coli DH5 alpha competent cells, the escherichia coli DH5 alpha competent cells are coated on an LB solid culture medium with 50 mu g/mL kanamycin and cultured at 37 ℃ overnight, positive clones are screened, and sgRNA expression frame plasmids containing two target site DNA fragments are extracted.
In one possible embodiment, sgT2 target site assembly is connected in the reaction systemBbsI after digestionThe volumes of the linearized sgRNA expression cassette plasmid, sgT2 target site DNA fragment, T4 DNA ligase Buffer and T4 DNA ligase are 15. mu.L, 2. mu.L and 1. mu.L, respectively.
Wherein the gene sequence table of the sgRNA expression cassette plasmid containing the DNA fragments of the two target sites is shown as SEQ ID NO. 1 in the specification.
Step (400): according to the primer FW and the primers RV and ddH2Preparing a reaction system of a linker primer pair with the volume ratio of O being 1:1:8, carrying out denaturation on the reaction system of the linker primer pair for 5min at 95 ℃ by using a PCR (polymerase chain reaction) amplification instrument, then cooling to 25 ℃ at the cooling rate of 0.2 ℃/s, and using ddH (ddH) to react products2Diluting by 250 times through O to obtain a linker DNA fragment, wherein the concentration of the primer FW and the concentration of the primer RV are both 100 mu Mol/L, and the linker primer pair comprises:
FW:5’-CGTACCTGCAGGAAAGCGGCCGCGTCAGGCGCGCCTAACT-3’、RV:5’-CTAGAGTTAGGCGCGCCTGACGCGGCCGCTTTCCTGCAGGTACGAGCT-3’。
in one possible embodiment, the primer FW and the primers RV and ddH in the reaction system of the linker primer pair2The volume of O was 1. mu.L, and 8. mu.L, respectively.
A step (500): the linker DNA fragment was ligated to the expression vector pCAMBIA2301 plasmidSacI andXbaand constructing pCAMBIA2301 plasmid containing linker DNA fragment between the enzyme cutting sites.
Preferably, the linker DNA fragment is ligated to the expression vector pCAMBIA2301 plasmidSacI andXbathe method comprises the following steps of constructing pCAMBIA2301 plasmid containing linker DNA fragment between enzyme cutting sites, wherein the pCAMBIA2301 plasmid comprises the following steps:
step (510): according to the method, 10 XNEB Buffer, pCAMBIA2301 plasmid and restriction enzymeSacI, restriction enzymeXbaⅠ、ddH2Preparing a first pCAMBIA2301 linear enzyme digestion reaction system with the volume ratio of O being 5:5:1:1:38, and using restriction enzyme for pCAMBIA2301 plasmidSacI andXbathe product is electrophoresed through agarose gel, and then the linearized pCAMBIA2301 plasmid is recovered.
In one possible embodiment of the method according to the invention,10 XNEB Buffer and pCAMBIA2301 plasmid, restriction enzyme in the first pCAMBIA2301 linear enzyme digestion reaction systemSacI, restriction enzymeXbaⅠ、ddH2The volumes of O were 5. mu.L, 1. mu.L, and 38. mu.L, respectively.
Step (520): preparing a Linker DNA fragment connection reaction system according to the volume ratio of the Linker DNA fragment to the linearized pCAMBIA2301 plasmid, T4 DNA ligase Buffer and T4 DNA ligase of 6:20:3:1, connecting the Linker DNA fragment and the linearized pCAMBIA2301 plasmid at 4 ℃ under the action of T4 DNA ligase Buffer and T4 DNA ligase overnight, transforming a connection product into an Escherichia coli DH5 alpha competent cell, coating the Escherichia coli DH5 alpha competent cell on an LB solid culture medium with 50 mu g/mL kanamycin, culturing at 37 ℃ overnight, screening positive clones, and extracting to obtain the pCAMBIA2301 plasmid containing the Linker DNA fragment.
In one possible embodiment, the volumes of the Linker DNA fragment, the linearized pCAMBIA2301 plasmid, the T4 DNA ligase Buffer and the T4 DNA ligase in the Linker DNA fragment ligation reaction system are respectively 6. mu.L, 20. mu.L, 3. mu.L and 1. mu.L.
A step (600): using restriction endonucleasesNotI andAsci, connecting Cas9 expression frame to pCAMBIA2301 plasmid containing linker DNA fragmentNotI andAsci, getting pCAMBIA2301 plasmid containing linker DNA fragment and Cas9 expression frame.
Preferably, the use of restriction enzymesNotI andAsci, connecting Cas9 expression frame to pCAMBIA2301 plasmid containing linker DNA fragmentNotI andAscthe method comprises the following steps of I, obtaining pCAMBIA2301 plasmid containing linker DNA fragment and Cas9 expression frame between enzyme cutting sites, wherein the pCAMBIA2301 plasmid comprises the following steps:
step (610): according to the method, 10 XNEB Buffer is mixed with pCAMBIA2301 plasmid containing linker DNA fragment and restriction enzymeNotI, restriction enzymeAscⅠ、ddH2Preparing a second pCAMBIA2301 linear enzyme digestion reaction system with the volume ratio of O to 5:5:1:1:38, and utilizing restriction enzymeNotI andAsci the pCAMBIA2301 plasmid containing linker DNA fragment andand carrying out double enzyme digestion on the Cas9 expression frame, carrying out agarose gel electrophoresis on the digestion product, cutting gel, and recovering a linearized pCAMBIA2301 plasmid containing a linker DNA fragment and a linearized Cas9 expression frame fragment.
In one possible embodiment, the second pCAMBIA2301 linearized reaction system is 10 XNEB Buffer, pCAMBIA2301 plasmid containing linker DNA fragment, restriction enzymeNotI, restriction enzymeAscⅠ、ddH2O is 5. mu.L, 1. mu.L, 38. mu.L, respectively.
Step (620): preparing a Cas9 expression frame fragment connection reaction system according to the volume ratio of a linearized Cas9 expression frame fragment to the linearized pCAMBIA2301 plasmid containing the linker DNA fragment, T4 DNA ligase Buffer and T4 DNA ligase being 6:20:3:1, connecting the linearized pCAMBIA2301 plasmid containing the linker DNA fragment and the linearized Cas9 expression frame fragment at the action of T4 DNA ligase Buffer and T4 DNA ligase at 4 ℃ overnight, transforming a connection product into Escherichia coli DH5 alpha competent cells, coating the cells on LB solid medium with 50 mu g/mL kanamycin at 37 ℃ for overnight, screening positive clones, and extracting the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frame.
In one possible embodiment, the volumes of the linearized Cas9 expression frame fragment and the linearized pCAMBIA2301 plasmid containing the linker DNA fragment, T4 DNA ligase Buffer and T4 DNA ligase in the Cas9 expression frame fragment ligation reaction system are 6. mu.L, 20. mu.L, 3. mu.L and 1. mu.L, respectively.
Step (700): using restriction endonucleasesNotI andSbfi, connecting the sgRNA expression frame plasmid containing the DNA fragments with the two target sites to the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frameNotI andSbfand I, obtaining an expression vector plasmid edited by the BoMYB101 gene between enzyme cutting sites.
Preferably, the use of restriction enzymesNotI andSbfi, connecting the sgRNA expression frame plasmid containing the DNA fragments with the two target sites to the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frameNotI andSbfthe method comprises the following steps of I, obtaining an expression vector plasmid edited by a BoMYB101 gene between enzyme cutting sites, wherein the steps comprise:
a step (710): mixing 10 XNEB Buffer with pCAMBIA2301 plasmid containing linker DNA fragment and Cas9 expression cassette, restriction endonucleaseNotI, restriction enzymeSbfⅠ、ddH2Preparing a third pCAMBIA2301 linear enzyme digestion reaction system with the volume ratio of O to 5:5:1:1:38, and utilizing restriction enzymeNotI andSbfthe pCAMBIA2301 plasmid containing a linker DNA fragment and a Cas9 expression frame and the sgRNA expression frame plasmid containing two target site DNA fragments are subjected to double enzyme digestion, the enzyme digestion products are subjected to agarose gel electrophoresis and then gel cutting to recover a linearized pCAMBIA2301 plasmid containing the linker DNA fragment and a Cas9 expression frame and a linearized sgRNA expression frame fragment containing the two target site DNA fragments.
In one possible embodiment, the third pCAMBIA2301 linearized reaction system is 10 XNEB Buffer, and pCAMBIA2301 plasmid containing linker DNA fragment and Cas9 expression cassette, restriction endonucleaseNotI, restriction enzymeSbfⅠ、ddH2O is 5. mu.L, 1. mu.L, 38. mu.L, respectively.
Step (720): preparing a sgRNA expression frame fragment connection reaction system according to the volume ratio of the sgRNA expression frame fragment which is linearized and contains two target site DNA fragments to the pCAMBIA2301 plasmid which is linearized and contains a linker DNA fragment and a Cas9 expression frame, the T4 DNA ligase Buffer and the T4 DNA ligase are 6:20:3:1, connecting the sgRNA expression frame fragment which is linearized and contains two target site DNA fragments and the pCAMBIA2301 plasmid which is linearized and contains the linker DNA fragment and the Cas9 expression frame at the action of the T4 DNA ligase Buffer and the T4 DNA ligase at 4 ℃ overnight, transforming a connecting product into Escherichia coli 5 alpha competent cells, coating the cells on LB solid medium with 50 mu g/mL of kanamycin, culturing at 37 ℃ overnight, screening positive clones, and extracting expression vector plasmids edited by the BoB 101 gene.
In one possible embodiment, the sgRNA expression frame fragment connecting the sgRNA expression frame fragment linearized in the reaction system and containing the two target site DNA fragments and the pCAMBIA2301 plasmid, T4 DNA ligase Buffer, T4 DNA ligase linearized containing the linker DNA fragment and the Cas9 expression frame have volumes of 6. mu.L, 20. mu.L, 3. mu.L, 1. mu.L, respectively.
In one possible embodiment, a schematic representation of an expression vector plasmid edited by the BoMYB101 gene can be shown in FIG. 1, where LB, RB are the left and right borders in FIG. 1; p 2X 35-spCas9-Tcamv is a Cas9 expression cassette; pBoU6-trna-sgRNA1-trna-sgRNA2-Tsp is broccoli U6 start sgRNA expression cassette; kan is kanamycin resistance gene.
Preferably, the method further comprises:
step (800): and transforming the expression vector plasmid edited by the BoMYB101 gene into an EHA105 agrobacterium-competent cell by using a freeze-thaw method to obtain the EHA105 agrobacterium strain containing the expression vector plasmid.
Step (900): infecting the broccoli hypocotyl explant by the EHA105 agrobacterium strain containing the expression vector plasmid, and obtaining a transgenic plant of which the expression vector is introduced into broccoli cells through resistance screening culture, wherein the transgenic plant specifically comprises the following steps:
(a) preparing the hypocotyls of the broccoli:
selecting 2M broccoli inbred line seeds with full and uniform seeds, sterilizing the 2M broccoli inbred line seeds for 45 s by using 75% alcohol, then sterilizing the 2M broccoli inbred line seeds for 15 min by using 10% sodium hypochlorite, and then rinsing the broccoli inbred line seeds for 5-6 times by using sterile water; uniformly sowing the disinfected seeds in 1/2 MS solid culture medium (preferably 30 seeds per bottle); culturing at 25 deg.C for 7 days under 16h illumination, cutting hypocotyl of aseptic seedling into small segments of about 1cm, and pre-culturing in broccoli differentiation medium (MS +30g/L sucrose +7g/L agar powder + 3.0 mg/L6-BA + 0.05 mg/L NAA pH5.8) for 2 days.
(b) And (3) agrobacterium culture and infection:
the EHA105 Agrobacterium strain containing the expression vector plasmid was picked up with an inoculating needle and streaked on a YEB solid medium plate containing Kan (50 mg/L) and Rif (50 mg/L), and placed in an oven at 28 ℃ for 2 days; picking single colony of positive clone in 5 ml liquid culture medium containing Kan (50 mg/L) and Rif (50 mg/L), and culturing for 2 days at 28 ℃ on a shaker with 225 rpm; 600 plus 700 mu L of bacterial liquid is taken on the day of infection and added to50 mL of YEB liquid without antibiotics, shaking and culturing at 28 ℃ and 225 rpm for 4 h to OD600Centrifuging at 4 deg.C and 4000 rpm for 10 min to obtain a supernatant, and suspending the thallus in 20 ml of ice-cold MS liquid culture medium (MS +20g/L sucrose pH 5.8); transferring the pre-cultured hypocotyl into a sterile bottle, and adding the suspension for infection for 15 min; transferring the hypocotyl to sterile filter paper, and blotting excess bacteria liquid on the hypocotyl, transferring to differential culture medium, and dark culturing for 2 days to obtain infected broccoli hypocotyl.
(c) Screening culture and callus induction:
transferring the infected cauliflower hypocotyls to a cauliflower screening culture medium (MS + 3.0 mg/L6-BA + 0.05 mg/L NAA +30g/L cane sugar +7g/L agar powder +400mg/L Cb +30mg/L Kan) for culture, and then replacing the culture medium every 14 days; cutting the adventitious bud which normally grows in the screening culture medium, inserting the cut adventitious bud into a rooting culture medium (MS + 0.2 mg/L NAA +30g/L sucrose +7g/L agar powder +400mg/L Cb +30mg/L Kan) for rooting; transplanting into soil when the root system grows to 1-2 cm to obtain Kan-resistant transgenic plants.
(d) Detecting transgenic plants:
a genomic DNA of a Kan-resistant transgenic plant is extracted by using a CTAB method, primers Cas9-F and Cas9-R (Cas 9-F: 5'-CGCAAGAACCGCATCTGCTACCTC-3', Cas 9-R: 5'-TTCTCGAGACGCCTGGACTTGGAG-3') are used for PCR amplification, and agarose gel electrophoresis is carried out to obtain a broccoli transgene detection schematic diagram as shown in figure 2, wherein in figure 2, a letter M is a DNA marker; the number "1-46" is Kan resistant plants; "+" is an expression vector plasmid as a positive control; "-" is the untransformed broccoli inbred line 2M as a negative control.
In order to further detect whether the BoMYB101 gene of the obtained Kan-resistant transgenic plant is mutated or not, synthetic primer pairs BoMYB101-F1+ BoMYB101-R1 and BoMYB101-F2+ BoMYB101-R2 (BoMYB 101-F1: 5'-ATGGACGGTGGTGAAGAGACGTC-3', BoMYB 101-R1: 5'-GAATAAAGGCAAACCAGCTCG-3', BoMYB 101-F2: 5'-CGTCGAATGAGTTATGTAATCC CGACC-3' and BoMYB 101-R2: 5'-GATTGATGAGAAGAGCTTAGATG-3') are designed at the upstream and downstream of target sites T1 and T2 respectively for PCR amplification, PCR products of 43 strains of transgenic materials are sequenced, the sequences of the target sites are compared with the sequences of corresponding wild-type plant PCR products, and the mutation of the genes is judged when the sequences of the target sites are changed or the sequencing peak images show the phenomenon. Comparing and analyzing the sequencing result, and finding that the target site sequence of the 43T 1 strain is not changed at all, wherein the editing efficiency is 0; 33 strains of the target site T2 have peak staggering or sequence change phenomena, the editing efficiency is 76.7%, PCR products of the target site T1 and T2 sequences of the broccoli BoMYB101 gene shown in figure 3 are directly sequenced to form a peak pattern, in figure 3, the target site T1 is not changed, and the target site T2 has a heavy peak or base change.
To further analyze the details of the editing of the target site gene sequence, a sequence fragment of a T2 target site amplified by a primer pair BoMYB101-F2+ BoMYB101-R2 of a #15 individual strain, #19 individual strain, #21 individual strain and #41 individual strain was inserted into pClone007 Simple Vector (Beijing Opticalke New technology Co., Ltd.). And transforming the connecting product into escherichia coli, coating the escherichia coli on a plate with 50 mg/L Amp for overnight culture at 37 ℃, selecting not less than 5 positive clones per single plant for sequencing analysis, and counting the base mutation type and frequency of the target gene. Among them, 7 monoclonals randomly selected from the #15 individual were sequenced: 1 base insertion occurs in 6 monoclonals, and deletion of a longer fragment (53 bases) occurs in 1 monoclone, and the editing frequency is 100%; the #19 single strain has 7 monoclonals which are subjected to deletion of 2 bases, and 1 monoclone which is not mutated; the 10 monoclonals detected by the #21 individual plant are all deletions of 10 basic groups, the editing frequency is 100 percent, and the plant is homozygous mutation; #41 individual strains randomly selected 9 monoclones for detection, 3 monoclones were subjected to single base insertion, 6 monoclones were subjected to 62 base deletion, the editing frequency was 100%, and the statistical chart of the single sequencing analysis of the target site T2 of the broccoli BoMYB101 gene is shown in FIG. 4.
The results show that the broccoli gene fixed-point editing method based on CRISPR/Cas9 provided by the invention can efficiently edit broccoli genes, even a homozygous mutant plant can be obtained in the T0 generation, and great help is provided for character observation or gene function research.
In summary, the CRISPR/Cas 9-based broccoli gene site-directed editing method provided by the invention is characterized in that CRISPR/Cas9 technology is used for performing site-directed knockout editing on broccoli BoMYB101 gene, 2 sgRNA target sites are designed according to broccoli BoMYB101 gene sequence, a knockout expression vector of the BoMYB101 gene is constructed, agrobacterium-mediated transformation of broccoli hypocotyl is performed, and molecular detection and screening of mutant plants are performed, so that high-efficiency broccoli gene editing plants are obtained, and application support is provided for character improvement and gene function research of disease resistance, cold resistance, breeding and the like of broccoli plants.
In addition, the CRISPR/Cas9 technology is used for carrying out base complementary pairing on a sgRNA sequence with a specific guide and a target sequence, guiding the Cas9 protein to be combined to the target sequence, carrying out DNA cutting to generate breakage, activating a non-homologous end connection or homologous recombination repair mechanism of a cell, and realizing mutation such as base deletion, insertion, substitution and the like. The CRISPR/Cas9 technology only modifies a target site sequence, an expression vector sequence in a T0 generation plant can be separated through progeny selfing to obtain a non-transgenic plant without any exogenous DNA sequence, and the mutant material is essentially indistinguishable from a mutant material obtained by a traditional breeding method, so that a new opportunity is provided for realizing an accurate, efficient, time-saving, labor-saving and safe agricultural breeding technology revolution, and a new technology is provided for broccoli breeding.
While the invention has been described in detail in the foregoing by way of general description, and specific embodiments and experiments, it will be apparent to those skilled in the art that modifications and improvements can be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.
Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. This invention is intended to cover any variations, uses, or adaptations of the invention following, in general, the principles of the invention and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains. It will be understood that the invention is not limited to the precise arrangements described above and shown in the drawings and that various modifications and changes may be made without departing from the scope thereof.
The sequence at the 1 st to 8 th sites in the sequence table 1 is a NotI restriction endonuclease recognition site;
the sequence of 537-556 th site in the sequence table 1 is a type II endonuclease BsaI recognition site;
the sequence at 815-th and 822-th sites in the sequence table 1 is an SbfI restriction enzyme recognition site;
the sequence of the 710 th and 731 th sites in the sequence table 1 is a type II endonuclease BbsI recognition site;
the sequence at 10826-10831 in the sequence table 2 is a SacI restriction endonuclease recognition site;
the sequence at 10847-10852 in the sequence table 2 is XbaI restriction endonuclease recognition site;
the sequence from 1 st to 8 th in the sequence table 3 is an AscI restriction endonuclease recognition site;
the sequence of 5336-position 5343 in the sequence table 3 is NotI restriction endonuclease recognition site;
the sequence at the 189-208 th site in the sequence table 4 is a target site T1 sequence;
the sequence at position 1168-1187 in the sequence table 4 is the target site T2 sequence.
Sequence listing
<110> Olympic species of Zhejiang America, Ltd
<120> broccoli gene site-directed editing method based on CRISPR/Cas9
<130> 2021.06.23
<150> 2021109424786
<151> 2021-08-17
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 822
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
gcggccgcct gataatataa aatctgttac ttctaaaact atacactatt tattctattt 60
tttgaatgaa agtatcttcg taaacacaca aaatattttg tgacgttgca attatacata 120
cacacaatat ctgcctcttc atactgacat tactgtgttc cctttcgtga ggtacgggcc 180
gagagagaac acagggtacg caccgattat gttcttatgc ccgcacaggg tacggaccgg 240
tcacctagta gtaactaaaa gctgatttac aaaaccatga atttttaaat gaatcacctt 300
ttgaataata ttaacgggcc agagagaaat cggagagagg cctgttagtg taataaacga 360
gcccattaat atgttgtaaa tgaagtgaaa cagtcccaca tcggttgtgt aagaagaaga 420
aactgtgttt atatagcgat ggagtgacga aggtgattga acaaagcacc agtggtctag 480
tggtagaata gtaccctgcc acggtacaga cccgggttcg attcccggct ggtgcaagag 540
accctgcagg gtctctgttt tagagctaga aatagcaagt taaaataagg ctagtccgtt 600
atcaacttga aaaagtggca ccgagtcggt gcaacaaagc accagtggtc tagtggtaga 660
atagtaccct gccacggtac agacccgggt tcgattcccg gctggtgcag ggtcttcgtt 720
acagaagacc tgttttagag ctagaaatag caagttaaaa taaggctagt ccgttatcaa 780
cttgaaaaag tggcaccgag tcggtgcttt ttttcctgca gg 822
<210> 2
<211> 11633
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
catggtagat ctgagggtaa atttctagtt tttctccttc attttcttgg ttaggaccct 60
tttctctttt tatttttttg agctttgatc tttctttaaa ctgatctatt ttttaattga 120
ttggttatgg tgtaaatatt acatagcttt aactgataat ctgattactt tatttcgtgt 180
gtctatgatg atgatgatag ttacagaacc gacgactcgt ccgtcctgta gaaaccccaa 240
cccgtgaaat caaaaaactc gacggcctgt gggcattcag tctggatcgc gaaaactgtg 300
gaattgatca gcgttggtgg gaaagcgcgt tacaagaaag ccgggcaatt gctgtgccag 360
gcagttttaa cgatcagttc gccgatgcag atattcgtaa ttatgcgggc aacgtctggt 420
atcagcgcga agtctttata ccgaaaggtt gggcaggcca gcgtatcgtg ctgcgtttcg 480
atgcggtcac tcattacggc aaagtgtggg tcaataatca ggaagtgatg gagcatcagg 540
gcggctatac gccatttgaa gccgatgtca cgccgtatgt tattgccggg aaaagtgtac 600
gtatcaccgt ttgtgtgaac aacgaactga actggcagac tatcccgccg ggaatggtga 660
ttaccgacga aaacggcaag aaaaagcagt cttacttcca tgatttcttt aactatgccg 720
gaatccatcg cagcgtaatg ctctacacca cgccgaacac ctgggtggac gatatcaccg 780
tggtgacgca tgtcgcgcaa gactgtaacc acgcgtctgt tgactggcag gtggtggcca 840
atggtgatgt cagcgttgaa ctgcgtgatg cggatcaaca ggtggttgca actggacaag 900
gcactagcgg gactttgcaa gtggtgaatc cgcacctctg gcaaccgggt gaaggttatc 960
tctatgaact cgaagtcaca gccaaaagcc agacagagtc tgatatctac ccgcttcgcg 1020
tcggcatccg gtcagtggca gtgaagggcc aacagttcct gattaaccac aaaccgttct 1080
actttactgg ctttggtcgt catgaagatg cggacttacg tggcaaagga ttcgataacg 1140
tgctgatggt gcacgaccac gcattaatgg actggattgg ggccaactcc taccgtacct 1200
cgcattaccc ttacgctgaa gagatgctcg actgggcaga tgaacatggc atcgtggtga 1260
ttgatgaaac tgctgctgtc ggctttcagc tgtctttagg cattggtttc gaagcgggca 1320
acaagccgaa agaactgtac agcgaagagg cagtcaacgg ggaaactcag caagcgcact 1380
tacaggcgat taaagagctg atagcgcgtg acaaaaacca cccaagcgtg gtgatgtgga 1440
gtattgccaa cgaaccggat acccgtccgc aaggtgcacg ggaatatttc gcgccactgg 1500
cggaagcaac gcgtaaactc gacccgacgc gtccgatcac ctgcgtcaat gtaatgttct 1560
gcgacgctca caccgatacc atcagcgatc tctttgatgt gctgtgcctg aaccgttatt 1620
acggatggta tgtccaaagc ggcgatttgg aaacggcaga gaaggtactg gaaaaagaac 1680
ttctggcctg gcaggagaaa ctgcatcagc cgattatcat caccgaatac ggcgtggata 1740
cgttagccgg gctgcactca atgtacaccg acatgtggag tgaagagtat cagtgtgcat 1800
ggctggatat gtatcaccgc gtctttgatc gcgtcagcgc cgtcgtcggt gaacaggtat 1860
ggaatttcgc cgattttgcg acctcgcaag gcatattgcg cgttggcggt aacaagaaag 1920
ggatcttcac tcgcgaccgc aaaccgaagt cggcggcttt tctgctgcaa aaacgctgga 1980
ctggcatgaa cttcggtgaa aaaccgcagc agggaggcaa acaagctagc caccaccacc 2040
accaccacgt gtgaattaca ggtgaccagc tcgaatttcc ccgatcgttc aaacatttgg 2100
caataaagtt tcttaagatt gaatcctgtt gccggtcttg cgatgattat catataattt 2160
ctgttgaatt acgttaagca tgtaataatt aacatgtaat gcatgacgtt atttatgaga 2220
tgggttttta tgattagagt cccgcaatta tacatttaat acgcgataga aaacaaaata 2280
tagcgcgcaa actaggataa attatcgcgc gcggtgtcat ctatgttact agatcgggaa 2340
ttaaactatc agtgtttgac aggatatatt ggcgggtaaa cctaagagaa aagagcgttt 2400
attagaataa cggatattta aaagggcgtg aaaaggttta tccgttcgtc catttgtatg 2460
tgcatgccaa ccacagggtt cccctcggga tcaaagtact ttgatccaac ccctccgctg 2520
ctatagtgca gtcggcttct gacgttcagt gcagccgtct tctgaaaacg acatgtcgca 2580
caagtcctaa gttacgcgac aggctgccgc cctgcccttt tcctggcgtt ttcttgtcgc 2640
gtgttttagt cgcataaagt agaatacttg cgactagaac cggagacatt acgccatgaa 2700
caagagcgcc gccgctggcc tgctgggcta tgcccgcgtc agcaccgacg accaggactt 2760
gaccaaccaa cgggccgaac tgcacgcggc cggctgcacc aagctgtttt ccgagaagat 2820
caccggcacc aggcgcgacc gcccggagct ggccaggatg cttgaccacc tacgccctgg 2880
cgacgttgtg acagtgacca ggctagaccg cctggcccgc agcacccgcg acctactgga 2940
cattgccgag cgcatccagg aggccggcgc gggcctgcgt agcctggcag agccgtgggc 3000
cgacaccacc acgccggccg gccgcatggt gttgaccgtg ttcgccggca ttgccgagtt 3060
cgagcgttcc ctaatcatcg accgcacccg gagcgggcgc gaggccgcca aggcccgagg 3120
cgtgaagttt ggcccccgcc ctaccctcac cccggcacag atcgcgcacg cccgcgagct 3180
gatcgaccag gaaggccgca ccgtgaaaga ggcggctgca ctgcttggcg tgcatcgctc 3240
gaccctgtac cgcgcacttg agcgcagcga ggaagtgacg cccaccgagg ccaggcggcg 3300
cggtgccttc cgtgaggacg cattgaccga ggccgacgcc ctggcggccg ccgagaatga 3360
acgccaagag gaacaagcat gaaaccgcac caggacggcc aggacgaacc gtttttcatt 3420
accgaagaga tcgaggcgga gatgatcgcg gccgggtacg tgttcgagcc gcccgcgcac 3480
gtctcaaccg tgcggctgca tgaaatcctg gccggtttgt ctgatgccaa gctggcggcc 3540
tggccggcca gcttggccgc tgaagaaacc gagcgccgcc gtctaaaaag gtgatgtgta 3600
tttgagtaaa acagcttgcg tcatgcggtc gctgcgtata tgatgcgatg agtaaataaa 3660
caaatacgca aggggaacgc atgaaggtta tcgctgtact taaccagaaa ggcgggtcag 3720
gcaagacgac catcgcaacc catctagccc gcgccctgca actcgccggg gccgatgttc 3780
tgttagtcga ttccgatccc cagggcagtg cccgcgattg ggcggccgtg cgggaagatc 3840
aaccgctaac cgttgtcggc atcgaccgcc cgacgattga ccgcgacgtg aaggccatcg 3900
gccggcgcga cttcgtagtg atcgacggag cgccccaggc ggcggacttg gctgtgtccg 3960
cgatcaaggc agccgacttc gtgctgattc cggtgcagcc aagcccttac gacatatggg 4020
ccaccgccga cctggtggag ctggttaagc agcgcattga ggtcacggat ggaaggctac 4080
aagcggcctt tgtcgtgtcg cgggcgatca aaggcacgcg catcggcggt gaggttgccg 4140
aggcgctggc cgggtacgag ctgcccattc ttgagtcccg tatcacgcag cgcgtgagct 4200
acccaggcac tgccgccgcc ggcacaaccg ttcttgaatc agaacccgag ggcgacgctg 4260
cccgcgaggt ccaggcgctg gccgctgaaa ttaaatcaaa actcatttga gttaatgagg 4320
taaagagaaa atgagcaaaa gcacaaacac gctaagtgcc ggccgtccga gcgcacgcag 4380
cagcaaggct gcaacgttgg ccagcctggc agacacgcca gccatgaagc gggtcaactt 4440
tcagttgccg gcggaggatc acaccaagct gaagatgtac gcggtacgcc aaggcaagac 4500
cattaccgag ctgctatctg aatacatcgc gcagctacca gagtaaatga gcaaatgaat 4560
aaatgagtag atgaatttta gcggctaaag gaggcggcat ggaaaatcaa gaacaaccag 4620
gcaccgacgc cgtggaatgc cccatgtgtg gaggaacggg cggttggcca ggcgtaagcg 4680
gctgggttgt ctgccggccc tgcaatggca ctggaacccc caagcccgag gaatcggcgt 4740
gacggtcgca aaccatccgg cccggtacaa atcggcgcgg cgctgggtga tgacctggtg 4800
gagaagttga aggccgcgca ggccgcccag cggcaacgca tcgaggcaga agcacgcccc 4860
ggtgaatcgt ggcaagcggc cgctgatcga atccgcaaag aatcccggca accgccggca 4920
gccggtgcgc cgtcgattag gaagccgccc aagggcgacg agcaaccaga ttttttcgtt 4980
ccgatgctct atgacgtggg cacccgcgat agtcgcagca tcatggacgt ggccgttttc 5040
cgtctgtcga agcgtgaccg acgagctggc gaggtgatcc gctacgagct tccagacggg 5100
cacgtagagg tttccgcagg gccggccggc atggccagtg tgtgggatta cgacctggta 5160
ctgatggcgg tttcccatct aaccgaatcc atgaaccgat accgggaagg gaagggagac 5220
aagcccggcc gcgtgttccg tccacacgtt gcggacgtac tcaagttctg ccggcgagcc 5280
gatggcggaa agcagaaaga cgacctggta gaaacctgca ttcggttaaa caccacgcac 5340
gttgccatgc agcgtacgaa gaaggccaag aacggccgcc tggtgacggt atccgagggt 5400
gaagccttga ttagccgcta caagatcgta aagagcgaaa ccgggcggcc ggagtacatc 5460
gagatcgagc tagctgattg gatgtaccgc gagatcacag aaggcaagaa cccggacgtg 5520
ctgacggttc accccgatta ctttttgatc gatcccggca tcggccgttt tctctaccgc 5580
ctggcacgcc gcgccgcagg caaggcagaa gccagatggt tgttcaagac gatctacgaa 5640
cgcagtggca gcgccggaga gttcaagaag ttctgtttca ccgtgcgcaa gctgatcggg 5700
tcaaatgacc tgccggagta cgatttgaag gaggaggcgg ggcaggctgg cccgatccta 5760
gtcatgcgct accgcaacct gatcgagggc gaagcatccg ccggttccta atgtacggag 5820
cagatgctag ggcaaattgc cctagcaggg gaaaaaggtc gaaaaggtct ctttcctgtg 5880
gatagcacgt acattgggaa cccaaagccg tacattggga accggaaccc gtacattggg 5940
aacccaaagc cgtacattgg gaaccggtca cacatgtaag tgactgatat aaaagagaaa 6000
aaaggcgatt tttccgccta aaactcttta aaacttatta aaactcttaa aacccgcctg 6060
gcctgtgcat aactgtctgg ccagcgcaca gccgaagagc tgcaaaaagc gcctaccctt 6120
cggtcgctgc gctccctacg ccccgccgct tcgcgtcggc ctatcgcggc cgctggccgc 6180
tcaaaaatgg ctggcctacg gccaggcaat ctaccagggc gcggacaagc cgcgccgtcg 6240
ccactcgacc gccggcgccc acatcaaggc accctgcctc gcgcgtttcg gtgatgacgg 6300
tgaaaacctc tgacacatgc agctcccgga gacggtcaca gcttgtctgt aagcggatgc 6360
cgggagcaga caagcccgtc agggcgcgtc agcgggtgtt ggcgggtgtc ggggcgcagc 6420
catgacccag tcacgtagcg atagcggagt gtatactggc ttaactatgc ggcatcagag 6480
cagattgtac tgagagtgca ccatatgcgg tgtgaaatac cgcacagatg cgtaaggaga 6540
aaataccgca tcaggcgctc ttccgcttcc tcgctcactg actcgctgcg ctcggtcgtt 6600
cggctgcggc gagcggtatc agctcactca aaggcggtaa tacggttatc cacagaatca 6660
ggggataacg caggaaagaa catgtgagca aaaggccagc aaaaggccag gaaccgtaaa 6720
aaggccgcgt tgctggcgtt tttccatagg ctccgccccc ctgacgagca tcacaaaaat 6780
cgacgctcaa gtcagaggtg gcgaaacccg acaggactat aaagatacca ggcgtttccc 6840
cctggaagct ccctcgtgcg ctctcctgtt ccgaccctgc cgcttaccgg atacctgtcc 6900
gcctttctcc cttcgggaag cgtggcgctt tctcatagct cacgctgtag gtatctcagt 6960
tcggtgtagg tcgttcgctc caagctgggc tgtgtgcacg aaccccccgt tcagcccgac 7020
cgctgcgcct tatccggtaa ctatcgtctt gagtccaacc cggtaagaca cgacttatcg 7080
ccactggcag cagccactgg taacaggatt agcagagcga ggtatgtagg cggtgctaca 7140
gagttcttga agtggtggcc taactacggc tacactagaa ggacagtatt tggtatctgc 7200
gctctgctga agccagttac cttcggaaaa agagttggta gctcttgatc cggcaaacaa 7260
accaccgctg gtagcggtgg tttttttgtt tgcaagcagc agattacgcg cagaaaaaaa 7320
ggatctcaag aagatccttt gatcttttct acggggtctg acgctcagtg gaacgaaaac 7380
tcacgttaag ggattttggt catgcattct aggtactaaa acaattcatc cagtaaaata 7440
taatatttta ttttctccca atcaggcttg atccccagta agtcaaaaaa tagctcgaca 7500
tactgttctt ccccgatatc ctccctgatc gaccggacgc agaaggcaat gtcataccac 7560
ttgtccgccc tgccgcttct cccaagatca ataaagccac ttactttgcc atctttcaca 7620
aagatgttgc tgtctcccag gtcgccgtgg gaaaagacaa gttcctcttc gggcttttcc 7680
gtctttaaaa aatcatacag ctcgcgcgga tctttaaatg gagtgtcttc ttcccagttt 7740
tcgcaatcca catcggccag atcgttattc agtaagtaat ccaattcggc taagcggctg 7800
tctaagctat tcgtataggg acaatccgat atgtcgatgg agtgaaagag cctgatgcac 7860
tccgcataca gctcgataat cttttcaggg ctttgttcat cttcatactc ttccgagcaa 7920
aggacgccat cggcctcact catgagcaga ttgctccagc catcatgccg ttcaaagtgc 7980
aggacctttg gaacaggcag ctttccttcc agccatagca tcatgtcctt ttcccgttcc 8040
acatcatagg tggtcccttt ataccggctg tccgtcattt ttaaatatag gttttcattt 8100
tctcccacca gcttatatac cttagcagga gacattcctt ccgtatcttt tacgcagcgg 8160
tatttttcga tcagtttttt caattccggt gatattctca ttttagccat ttattatttc 8220
cttcctcttt tctacagtat ttaaagatac cccaagaagc taattataac aagacgaact 8280
ccaattcact gttccttgca ttctaaaacc ttaaatacca gaaaacagct ttttcaaagt 8340
tgttttcaaa gttggcgtat aacatagtat cgacggagcc gattttgaaa ccgcggtgat 8400
cacaggcagc aacgctctgt catcgttaca atcaacatgc taccctccgc gagatcatcc 8460
gtgtttcaaa cccggcagct tagttgccgt tcttccgaat agcatcggta acatgagcaa 8520
agtctgccgc cttacaacgg ctctcccgct gacgccgtcc cggactgatg ggctgcctgt 8580
atcgagtggt gattttgtgc cgagctgccg gtcggggagc tgttggctgg ctggtggcag 8640
gatatattgt ggtgtaaaca aattgacgct tagacaactt aataacacat tgcggacgtt 8700
tttaatgtac tgaattaacg ccgaattaat tcgggggatc tggattttag tactggattt 8760
tggttttagg aattagaaat tttattgata gaagtatttt acaaatacaa atacatacta 8820
agggtttctt atatgctcaa cacatgagcg aaaccctata ggaaccctaa ttcccttatc 8880
tgggaactac tcacacatta ttatggagaa actcgagctt gtcgatcgac tctagctaga 8940
ggatcgatcc gaaccccaga gtcccgctca gaagaactcg tcaagaaggc gatagaaggc 9000
gatgcgctgc gaatcgggag cggcgatacc gtaaagcacg aggaagcggt cagcccattc 9060
gccgccaagc tcttcagcaa tatcacgggt agccaacgct atgtcctgat agcggtccgc 9120
cacacccagc cggccacagt cgatgaatcc agaaaagcgg ccattttcca ccatgatatt 9180
cggcaagcag gcatcgccat gtgtcacgac gagatcctcg ccgtcgggca tgcgcgcctt 9240
gagcctggcg aacagttcgg ctggcgcgag cccctgatgc tcttcgtcca gatcatcctg 9300
atcgacaaga ccggcttcca tccgagtacg tgctcgctcg atgcgatgtt tcgcttggtg 9360
gtcgaatggg caggtagccg gatcaagcgt atgcagccgc cgcattgcat cagccatgat 9420
ggatactttc tcggcaggag caaggtgaga tgacaggaga tcctgccccg gcacttcgcc 9480
caatagcagc cagtcccttc ccgcttcagt gacaacgtcg agcacagctg cgcaaggaac 9540
gcccgtcgtg gccagccacg atagccgcgc tgcctcgtcc tggagttcat tcagggcacc 9600
ggacaggtcg gtcttgacaa aaagaaccgg gcgcccctgc gctgacagcc ggaacacggc 9660
ggcatcagag cagccgattg tctgttgtgc ccagtcatag ccgaatagcc tctccaccca 9720
agcggccgga gaacctgcgt gcaatccatc ttgttcaatc cccatggtcg atcgacagat 9780
ctgcgaaagc tcgagagaga tagatttgta gagagagact ggtgatttca gcgtgtcctc 9840
tccaaatgaa atgaacttcc ttatatagag gaaggtcttg cgaaggatag tgggattgtg 9900
cgtcatccct tacgtcagtg gagatatcac atcaatccac ttgctttgaa gacgtggttg 9960
gaacgtcttc tttttccacg atgctcctcg tgggtggggg tccatctttg ggaccactgt 10020
cggcagaggc atcttgaacg atagcctttc ctttatcgca atgatggcat ttgtaggtgc 10080
caccttcctt ttctactgtc cttttgatga agtgacagat agctgggcaa tggaatccga 10140
ggaggtttcc cgatattacc ctttgttgaa aagtctcaat agccctttgg tcttctgaga 10200
ctgtatcttt gatattcttg gagtagacga gagtgtcgtg ctccaccatg ttatcacatc 10260
aatccacttg ctttgaagac gtggttggaa cgtcttcttt ttccacgatg ctcctcgtgg 10320
gtgggggtcc atctttggga ccactgtcgg cagaggcatc ttgaacgata gcctttcctt 10380
tatcgcaatg atggcatttg taggtgccac cttccttttc tactgtcctt ttgatgaagt 10440
gacagatagc tgggcaatgg aatccgagga ggtttcccga tattaccctt tgttgaaaag 10500
tctcaatagc cctttggtct tctgagactg tatctttgat attcttggag tagacgagag 10560
tgtcgtgctc caccatgttg gcaagctgct ctagccaata cgcaaaccgc ctctccccgc 10620
gcgttggccg attcattaat gcagctggca cgacaggttt cccgactgga aagcgggcag 10680
tgagcgcaac gcaattaatg tgagttagct cactcattag gcaccccagg ctttacactt 10740
tatgcttccg gctcgtatgt tgtgtggaat tgtgagcgga taacaatttc acacaggaaa 10800
cagctatgac catgattacg aattcgagct cggtacccgg ggatcctcta gagtcgacct 10860
gcaggcatgc aagcttggca ctggccgtcg ttttacaacg tcgtgactgg gaaaaccctg 10920
gcgttaccca acttaatcgc cttgcagcac atcccccttt cgccagctgg cgtaatagcg 10980
aagaggcccg caccgatcgc ccttcccaac agttgcgcag cctgaatggc gaatgctaga 11040
gcagcttgag cttggatcag attgtcgttt cccgccttca gtttagcttc atggagtcaa 11100
agattcaaat agaggaccta acagaactcg ccgtaaagac tggcgaacag ttcatacaga 11160
gtctcttacg actcaatgac aagaagaaaa tcttcgtcaa catggtggag cacgacacac 11220
ttgtctactc caaaaatatc aaagatacag tctcagaaga ccaaagggca attgagactt 11280
ttcaacaaag ggtaatatcc ggaaacctcc tcggattcca ttgcccagct atctgtcact 11340
ttattgtgaa gatagtggaa aaggaaggtg gctcctacaa atgccatcat tgcgataaag 11400
gaaaggccat cgttgaagat gcctctgccg acagtggtcc caaagatgga cccccaccca 11460
cgaggagcat cgtggaaaaa gaagacgttc caaccacgtc ttcaaagcaa gtggattgat 11520
gtgatatctc cactgacgta agggatgacg cacaatccca ctatccttcg caagaccctt 11580
cctctatata aggaagttca tttcatttgg agagaacacg ggggactctt gac 11633
<210> 3
<211> 5343
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
ggcgcgcctt accggtcaac atgtggagca cgacacactt gtctactcca aaaatatcaa 60
agatacagtc tcagaagacc aaagggcaat tgagactttt caacaaaggg taatatccgg 120
aaacctcctc ggattccatt gcccagctat ctgtcacttt attgtgaaga tagtggaaaa 180
ggaaggtggc tcctacaaat gccatcattg cgataaagga aaggccatcg ttgaagatgc 240
ctctgccgac agtggtccca aagatggacc cccacccacg aggagcatcg tggaaaaaga 300
agacgttcca accacgtctt caaagcaagt ggattgatgt gataacatgg tggagcacga 360
cacacttgtc tactccaaaa atatcaaaga tacagtctca gaagaccaaa gggcaattga 420
gacttttcaa caaagggtaa tatccggaaa cctcctcgga ttccattgcc cagctatctg 480
tcactttatt gtgaagatag tggaaaagga aggtggctcc tacaaatgcc atcattgcga 540
taaaggaaag gccatcgttg aagatgcctc tgccgacagt ggtcccaaag atggaccccc 600
acccacgagg agcatcgtgg aaaaagaaga cgttccaacc acgtcttcaa agcaagtgga 660
ttgatgtgat atctccactg acgtaaggga tgacgcacaa tcccactatc cttcgcaaga 720
cccttcctct atataaggaa gttcatttca tttggagagg acgtcgagag ttctcaacac 780
aacatataca aaacaaacga atctcaagca atcaagcatt ctacttctat tgcagcaatt 840
taaatcattt cttttaaagc aaaagcaatt ttctgaaaat tttcaccatt tacgaacgat 900
agccatggct cctaagaaga agcggaaggt tggtattcac ggggtgcctg cggctgacaa 960
gaagtactcc atcggcctcg acatcggcac caacagcgtc ggctgggcgg tgatcaccga 1020
cgagtacaag gtcccgtcca agaagttcaa ggtcctgggc aacaccgacc gccactccat 1080
caagaagaac ctcatcggcg ccctcctctt cgactccggc gagacggcgg aggcgacccg 1140
cctcaagcgc accgcccgcc gccgctacac ccgccgcaag aaccgcatct gctacctcca 1200
ggagatcttc tccaacgaga tggcgaaggt cgacgactcc ttcttccacc gcctcgagga 1260
gtccttcctc gtggaggagg acaagaagca cgagcgccac cccatcttcg gcaacatcgt 1320
cgacgaggtc gcctaccacg agaagtaccc cactatctac caccttcgta agaagcttgt 1380
tgactctact gataaggctg atcttcgtct catctacctt gctctcgctc acatgatcaa 1440
gttccgtggt cacttcctta tcgagggtga ccttaaccct gataactccg acgtggacaa 1500
gctcttcatc cagctcgtcc agacctacaa ccagctcttc gaggagaacc ctatcaacgc 1560
ttccggtgtc gacgctaagg cgatcctttc cgctaggctc tccaagtcca ggcgtctcga 1620
gaacctcatc gcccagctcc ctggtgagaa gaagaacggt cttttcggta acctcatcgc 1680
tctctccctc ggtctgaccc ctaacttcaa gtccaacttc gacctcgctg aggacgctaa 1740
gcttcagctc tccaaggata cctacgacga tgatctcgac aacctcctcg ctcagattgg 1800
agatcagtac gctgatctct tccttgctgc taagaacctc tccgatgcta tcctcctttc 1860
ggatatcctt agggttaaca ctgagatcac taaggctcct ctttctgctt ccatgatcaa 1920
gcgctacgac gagcaccacc aggacctcac cctcctcaag gctcttgttc gtcagcagct 1980
ccccgagaag tacaaggaga tcttcttcga ccagtccaag aacggctacg ccggttacat 2040
tgacggtgga gctagccagg aggagttcta caagttcatc aagccaatcc ttgagaagat 2100
ggatggtact gaggagcttc tcgttaagct taaccgtgag gacctcctta ggaagcagag 2160
gactttcgat aacggctcta tccctcacca gatccacctt ggtgagcttc acgccatcct 2220
tcgtaggcag gaggacttct accctttcct caaggacaac cgtgagaaga tcgagaagat 2280
ccttactttc cgtattcctt actacgttgg tcctcttgct cgtggtaact cccgtttcgc 2340
ttggatgact aggaagtccg aggagactat caccccttgg aacttcgagg aggttgttga 2400
caagggtgct tccgcccagt ccttcatcga gcgcatgacc aacttcgaca agaacctccc 2460
caacgagaag gtcctcccca agcactccct cctctacgag tacttcacgg tctacaacga 2520
gctcaccaag gtcaagtacg tcaccgaggg tatgcgcaag cctgccttcc tctccggcga 2580
gcagaagaag gctatcgttg acctcctctt caagaccaac cgcaaggtca ccgtcaagca 2640
gctcaaggag gactacttca agaagatcga gtgcttcgac tccgtcgaga tcagcggcgt 2700
tgaggaccgt ttcaacgctt ctctcggtac ctaccacgat ctcctcaaga tcatcaagga 2760
caaggacttc ctcgacaacg aggagaacga ggacatcctc gaggacatcg tcctcactct 2820
tactctcttc gaggataggg agatgatcga ggagaggctc aagacttacg ctcatctctt 2880
cgatgacaag gttatgaagc agctcaagcg tcgccgttac accggttggg gtaggctctc 2940
ccgcaagctc atcaacggta tcagggataa gcagagcggc aagactatcc tcgacttcct 3000
caagtctgat ggtttcgcta acaggaactt catgcagctc atccacgatg actctcttac 3060
cttcaaggag gatattcaga aggctcaggt gtccggtcag ggcgactctc tccacgagca 3120
cattgctaac cttgctggtt cccctgctat caagaagggc atccttcaga ctgttaaggt 3180
tgtcgatgag cttgtcaagg ttatgggtcg tcacaagcct gagaacatcg tcatcgagat 3240
ggctcgtgag aaccagacta cccagaaggg tcagaagaac tcgagggagc gcatgaagag 3300
gattgaggag ggtatcaagg agcttggttc tcagatcctt aaggagcacc ctgtcgagaa 3360
cacccagctc cagaacgaga agctctacct ctactacctc cagaacggta gggatatgta 3420
cgttgaccag gagctcgaca tcaacaggct ttctgactac gacgtcgacc acattgttcc 3480
tcagtctttc cttaaggatg actccatcga caacaaggtc ctcacgaggt ccgacaagaa 3540
caggggtaag tcggacaacg tcccttccga ggaggttgtc aagaagatga agaactactg 3600
gaggcagctt ctcaacgcta agctcattac ccagaggaag ttcgacaacc tcacgaaggc 3660
tgagaggggt ggcctttccg agcttgacaa ggctggtttc atcaagaggc agcttgttga 3720
gacgaggcag attaccaagc acgttgctca gatcctcgat tctaggatga acaccaagta 3780
cgacgagaac gacaagctca tccgcgaggt caaggtgatc accctcaagt ccaagctcgt 3840
ctccgacttc cgcaaggact tccagttcta caaggtccgc gagatcaaca actaccacca 3900
cgctcacgat gcttacctta acgctgtcgt tggtaccgct cttatcaaga agtaccctaa 3960
gcttgagtcc gagttcgtct acggtgacta caaggtctac gacgttcgta agatgatcgc 4020
caagtccgag caggagatcg gcaaggccac cgccaagtac ttcttctact ccaacatcat 4080
gaacttcttc aagaccgaga tcaccctcgc caacggcgag atccgcaagc gccctcttat 4140
cgagacgaac ggtgagactg gtgagatcgt ttgggacaag ggtcgcgact tcgctactgt 4200
tcgcaaggtc ctttctatgc ctcaggttaa catcgtcaag aagaccgagg tccagaccgg 4260
tggcttctcc aaggagtcta tccttccaaa gagaaactcg gacaagctca tcgctaggaa 4320
gaaggattgg gaccctaaga agtacggtgg tttcgactcc cctactgtcg cctactccgt 4380
cctcgtggtc gccaaggtgg agaagggtaa gtcgaagaag ctcaagtccg tcaaggagct 4440
cctcggcatc accatcatgg agcgctcctc cttcgagaag aacccgatcg acttcctcga 4500
ggccaagggc tacaaggagg tcaagaagga cctcatcatc aagctcccca agtactctct 4560
tttcgagctc gagaacggtc gtaagaggat gctggcttcc gctggtgagc tccagaaggg 4620
taacgagctt gctcttcctt ccaagtacgt gaacttcctc tacctcgcct cccactacga 4680
gaagctcaag ggttcccctg aggataacga gcagaagcag ctcttcgtgg agcagcacaa 4740
gcactacctc gacgagatca tcgagcagat ctccgagttc tccaagcgcg tcatcctcgc 4800
tgacgctaac ctcgacaagg tcctctccgc ctacaacaag caccgcgaca agcccatccg 4860
cgagcaggcc gagaacatca tccacctctt cacgctcacg aacctcggcg cccctgctgc 4920
tttcaagtac ttcgacacca ccatcgacag gaagcgttac acgtccacca aggaggttct 4980
cgacgctact ctcatccacc agtccatcac cggtctttac gagactcgta tcgacctttc 5040
ccagcttggt ggtgataagc gtcctgctgc caccaaaaag gccggacagg ctaagaaaaa 5100
gaagtaggat ccacctgatc tagagtccgc aaaaatcacc agtctctctc tacaaatcta 5160
tctctctcta tttttctcca gaataatgtg tgagtagttc ccagataagg gaattagggt 5220
tcttataggg tttcgctcat gtgttgagca tataagaaac ccttagtatg tatttgtatt 5280
tgtaaaatac ttctatcaat aaaatttcta attcctaaaa ccaaaatcca gtgacgcggc 5340
cgc 5343
<210> 4
<211> 1914
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
atggacggtg gtgaagagac gtcgacggcg agagggctga agaaaggtcc atggacgacg 60
acagaggatg cgatcttgac ggagtacgtg aggaaacgcg gtgaaggtaa ctggaacgcg 120
gtgcagaaga actcaggctt gctccggtgt gggaaaagct gccgtctacg gtgggcgaac 180
catctccggc caaatctaag gacaggatcc tttagtcctg atgaagagaa gatcatcatc 240
gagcttcacg ctaagttggg taacaaatgg gctcgtatgg cttctcaggt ttattttctc 300
ataaacaata ttttctcatt taaaaaatca cttattattc tccttatttg ttacttcaat 360
tctagaatta cagagcttta aatttttata tgcaattaaa attttctagt taaacacata 420
aattgcatgt ttcagtgtgt tttgaatcta ccgtctcttt ggtttggcat gattaatctt 480
gcatctcttc tattgctttt ttttatcctt ttagttgtaa aggttttttt tctattgtag 540
ttacctggaa gaactgacaa cgaaatcaaa aactattgga acacgaggat aaagagaaga 600
caacgagctg gtttgccttt attccctcac gagattcagc atctagggat tggtaatgat 660
gatgagtttg agattagatg ctttcagttc ccaaaccaag accatcctaa tcaccaaaat 720
atgattcaat acactaattc ctctaatact tcaccatcct cgtcttcatt ctcttcatca 780
tcttctcaac ctccaaaaga gctgtgttta gatcccttaa tctctactaa tcccggcctt 840
aatcagatcc ccaatatgtt ctctccttac aacaatagct ttgagaatga caataaccag 900
tttgttttct ctcttccttt ttcctcatcc tcatcgtcga atgagttatg taatcccgac 960
caacttcttg aactcatgtc agagaatttg gacacaaacg ttatcagtaa gaaagacatt 1020
gacgctacga gtcttattag agatcatgag acgataccga gttatttctc tttaggacta 1080
gacactaccg tcctagagct tccttcaaac caaacaccga ctcaatcgtg cacttccaat 1140
attatgcttt acaataatgt ccttcttgat tcacctgcgg ggaacagtgg attacttgac 1200
gccctcttgg aggaatctcg agccttgtct cgcggcggaa tcttcaagga cgctagggtt 1260
tcttcgagtg gtctatgtga ggatcaagac aagagagtga agatgaaatt tgagaatcgg 1320
ttgatagatc atctaagctc ttctcatcaa tcatcatttg gtaagaagcg ttatatgaat 1380
tcaaaccatt ttcacttata cattattttt tgctataacc attaatttat atttaataga 1440
aggcctagta gagatgattt gatccaaaaa aaagccaagt agatatgttt aatcaaagtg 1500
aaaccgaatc tagtttggat cttcggtaat atcgaataca tatttgattt ttactaatca 1560
tgtatttcat gttaatttgt gtttaataca tattaatctt aaaatgaaca gaatcaaact 1620
ctaatcttta cgagaagcac aatgacgcaa cgatgttgaa ggcaacagtg gatgatgatg 1680
acgacgacat gttgaagagc cttctcaaca gtttcccttc aaccacaccg ttacctgatt 1740
ggtaccagac gacagagatc ctaaaaggag gcctcaccga gcggaatatt gataggacac 1800
catcagggta ataacagggt ggagccacac aagccaccac cttcttccaa tgtagatcct 1860
atggcctcct tagggtcatc atcctactgg ggaaacatac ctagaatctg ctag 1914
Claims (6)
1. A method for editing broccoli genes in a fixed point manner based on CRISPR/Cas9, which is characterized by comprising the following steps:
obtaining a BoMYB101 gene sequence according to broccoli inbred line 2M genome sequencing analysis, selecting 5'-GCCAAATCTAAGGACAGGAT-3' sequence as a target site sgT1 from a first exon of the BoMYB101 gene sequence, selecting 5'-GATTCACCTGCGGGGAACAG-3' sequence as a target site sgT2 from a second exon of the BoMYB101 gene sequence, and respectively synthesizing complementary primer pairs corresponding to the target sites, wherein the complementary primer pairs corresponding to the target sites sgT1 comprise:
sgT1-F:5’-TGCAGCCAAATCTAAGGACAGGAT-3’、sgT1-R:5’-AAACATCCTGTCCTTAGATTTGGC-3’;
the complementary primer pair corresponding to target site sgT2 includes:
sgT2-F:5’-TGCAGATTCACCTGCGGGGAACAG-3’、sgT2-R:5’-AAACCTGTTCCCCGCAGGTGAATC-3’;
for each complementary primer pair, according to primer F and primer R, ddH2Preparing a reaction system of the complementary primer pair with the volume ratio of O being 1:1:8, carrying out 95 ℃ denaturation on the reaction system of the complementary primer pair for 5min by using a PCR (polymerase chain reaction) amplification instrument, then cooling to 25 ℃ at the cooling rate of 0.2 ℃/s, and using ddH (ddH) to react products2Diluting by 250 times through O to obtain DNA fragments of each target site, wherein the concentrations of the primer F and the primer R are both 100 mu Mol/L;
connecting each target site DNA fragment to a sgRNA expression frame respectively to construct a sgRNA expression frame plasmid containing two target site DNA fragments;
according to the primer FW and the primers RV and ddH2Preparing a reaction system of a linker primer pair with the volume ratio of O being 1:1:8, carrying out denaturation on the reaction system of the linker primer pair for 5min at 95 ℃ by using a PCR (polymerase chain reaction) amplification instrument, then cooling to 25 ℃ at the cooling rate of 0.2 ℃/s, and using ddH (ddH) to react products2Diluting by 250 times through O to obtain a linker DNA fragment, wherein the concentration of the primer FW and the concentration of the primer RV are both 100 mu Mol/L, and the linker primer pair comprises:
FW:5’-CGTACCTGCAGGAAAGCGGCCGCGTCAGGCGCGCCTAACT-3’、RV:5’-CTAGAGTTAGGCGCGCCTGACGCGGCCGCTTTCCTGCAGGTACGAGCT-3’;
the linker DNA fragment was ligated to the expression vector pCAMBIA2301 plasmidSacI andXbaconstructing pCAMBIA2301 plasmid containing linker DNA fragment between enzyme cutting sites I;
using restriction endonucleasesNotI andAsci, connecting Cas9 expression frame to pCAMBIA2301 plasmid containing linker DNA fragmentNotI andAscobtaining pCAMBIA2301 plasmid containing linker DNA fragment and Cas9 expression frame between enzyme cutting sites;
using restriction endonucleasesNotI andSbfi, mixingThe sgRNA expression frame plasmid containing the DNA fragments of the two target sites is connected to the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frameNotI andSbfi, obtaining an expression vector plasmid edited by a BoMYB101 gene between enzyme cutting sites;
transforming the expression vector plasmid edited by the BoMYB101 gene into an EHA105 agrobacterium-competent cell by using a freeze-thaw method to obtain an EHA105 agrobacterium strain containing the expression vector plasmid;
and infecting the broccoli hypocotyl explant by the EHA105 agrobacterium strain containing the expression vector plasmid, and obtaining a transgenic plant of which the expression vector is introduced into broccoli cells through resistance screening culture.
2. The method according to claim 1, wherein the step of ligating each target site sequence fragment into a sgRNA expression cassette, respectively, to construct a sgRNA expression cassette plasmid containing two target site DNA fragments comprises:
according to the expression frame plasmid of 10 XNEB Buffer 2.1 and sgRNA and endonucleaseBsaⅠ、ddH2Preparing a sgRNA expression frame enzyme digestion reaction system corresponding to sgT1 target sites with the volume ratio of O being 3:4:1:22, and using the endonuclease of type II endonuclease site for the sgRNA expression frame plasmidBsaI, enzyme digestion, carrying out agarose gel electrophoresis on the enzyme digestion product, cutting the gel and recycling to obtain the productBsaI, digesting a linearized sgRNA expression frame plasmid;
preparing a sgT1 target site assembly and connection reaction system according to the volume ratio of the linearized sgRNA expression frame plasmid after Bsa I digestion to the sgT1 target site DNA fragment, the T4 DNA ligase Buffer and the T4 DNA ligase of 15:2:2:1, and mixing the sgT1 target site DNA fragment and the DNA fragment of the sgT1 target siteBsaI, connecting the linearized sgRNA expression frame plasmid subjected to enzyme digestion at 4 ℃ overnight under the action of T4 DNA ligase Buffer and T4 DNA ligase, then transforming a connecting product into an escherichia coli DH5 alpha competent cell, coating the competent cell on an LB solid culture medium with 50 mu g/mL kanamycin, culturing at 37 ℃ overnight, screening positive clones, and extracting to obtain a sgRNA expression frame plasmid containing a sgT1 target site DNA fragment;
according to the ratio of 10 XNEB Buffer 2.1 to sg of DNA fragment containing sgT1 target siteRNA expression cassette plasmid, endonucleaseBbsⅠ、ddH2Preparing a sgRNA expression frame enzyme digestion reaction system corresponding to sgT2 target sites with the volume ratio of O being 3:4:1:22, and carrying out endonuclease treatment on the sgRNA expression frame plasmid containing the DNA fragment with the sgT1 target sites by using type II endonuclease sitesBbsI, enzyme digestion, carrying out agarose gel electrophoresis on the enzyme digestion product, cutting the gel and recycling to obtain the productBbsI, digesting a linearized sgRNA expression frame plasmid;
according toBbsI, preparing a sgT2 target site assembly and connection reaction system by carrying out enzyme digestion on a linearized sgRNA expression cassette plasmid, an sgT2 target site DNA fragment, a T4 DNA ligase Buffer and a T4 DNA ligase in a volume ratio of 15:2:2:1, and carrying out enzyme digestion on the sgRNA expression cassette plasmid and the DNA fragment of the target site sgT2BbsI after enzyme digestion, linearized sgRNA expression frame plasmids are connected at 4 ℃ overnight under the action of T4 DNA ligase Buffer and T4 DNA ligase, then a connection product is transformed into escherichia coli DH5 alpha competent cells, the escherichia coli DH5 alpha competent cells are coated on an LB solid culture medium with 50 mu g/mL kanamycin and cultured at 37 ℃ overnight, positive clones are screened, and sgRNA expression frame plasmids containing two target site DNA fragments are extracted.
3. The method according to claim 1, wherein the linker DNA fragment is ligated to the expression vector pCAMBIA2301 plasmidSacI andXbathe method comprises the following steps of constructing pCAMBIA2301 plasmid containing linker DNA fragment between enzyme cutting sites, wherein the pCAMBIA2301 plasmid comprises the following steps:
according to the method, 10 XNEB Buffer, pCAMBIA2301 plasmid and restriction enzymeSacI, restriction enzymeXbaⅠ、ddH2Preparing a first pCAMBIA2301 linear enzyme digestion reaction system with the volume ratio of O being 5:5:1:1:38, and using restriction enzyme for pCAMBIA2301 plasmidSacI andXbacarrying out double digestion, carrying out agarose gel electrophoresis on a digestion product, cutting gel, and recovering a linearized pCAMBIA2301 plasmid;
preparing a Linker DNA fragment connection reaction system according to the volume ratio of the Linker DNA fragment to the linearized pCAMBIA2301 plasmid, T4 DNA ligase Buffer and T4 DNA ligase of 6:20:3:1, connecting the Linker DNA fragment and the linearized pCAMBIA2301 plasmid at 4 ℃ under the action of T4 DNA ligase Buffer and T4 DNA ligase overnight, transforming a connection product into an Escherichia coli DH5 alpha competent cell, coating the Escherichia coli DH5 alpha competent cell on an LB solid culture medium with 50 mu g/mL kanamycin, culturing at 37 ℃ overnight, screening positive clones, and extracting to obtain the pCAMBIA2301 plasmid containing the Linker DNA fragment.
4. The method according to claim 1, wherein the restriction enzyme is usedNotI andAsci, connecting Cas9 expression frame to pCAMBIA2301 plasmid containing linker DNA fragmentNotI andAscthe method comprises the following steps of I, obtaining pCAMBIA2301 plasmid containing linker DNA fragment and Cas9 expression frame between enzyme cutting sites, wherein the pCAMBIA2301 plasmid comprises the following steps:
according to the method, 10 XNEB Buffer is mixed with pCAMBIA2301 plasmid containing linker DNA fragment and restriction enzymeNotI, restriction enzymeAscⅠ、ddH2Preparing a second pCAMBIA2301 linear enzyme digestion reaction system with the volume ratio of O to 5:5:1:1:38, and utilizing restriction enzymeNotI andAsccarrying out double enzyme digestion on the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frame, carrying out agarose gel electrophoresis on the enzyme digestion product, cutting gel, and recovering the linearized pCAMBIA2301 plasmid containing the linker DNA fragment and the linearized Cas9 expression frame fragment;
preparing a Cas9 expression frame fragment connection reaction system according to the volume ratio of a linearized Cas9 expression frame fragment to the linearized pCAMBIA2301 plasmid containing the linker DNA fragment, T4 DNA ligase Buffer and T4 DNA ligase being 6:20:3:1, connecting the linearized pCAMBIA2301 plasmid containing the linker DNA fragment and the linearized Cas9 expression frame fragment at the action of T4 DNA ligase Buffer and T4 DNA ligase at 4 ℃ overnight, transforming a connection product into Escherichia coli DH5 alpha competent cells, coating the cells on LB solid medium with 50 mu g/mL kanamycin at 37 ℃ for overnight, screening positive clones, and extracting the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frame.
5. The method according to claim 1, wherein the restriction enzyme is usedNotI andSbfi, subjecting the DNA piece containing the two target sitesThe sgRNA expression frame plasmid of the segment is connected to the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frameNotI andSbfthe method comprises the following steps of I, obtaining an expression vector plasmid edited by a BoMYB101 gene between enzyme cutting sites, wherein the steps comprise:
mixing 10 XNEB Buffer with pCAMBIA2301 plasmid containing linker DNA fragment and Cas9 expression cassette, restriction endonucleaseNotI, restriction enzymeSbfⅠ、ddH2Preparing a third pCAMBIA2301 linear enzyme digestion reaction system with the volume ratio of O to 5:5:1:1:38, and utilizing restriction enzymeNotI andSbfcarrying out double enzyme digestion on the pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frame and the sgRNA expression frame plasmid containing the two target site DNA fragments, carrying out agarose gel electrophoresis on the digestion products, cutting gel, and recovering a linearized pCAMBIA2301 plasmid containing the linker DNA fragment and the Cas9 expression frame and a linearized sgRNA expression frame fragment containing the two target site DNA fragments;
preparing a sgRNA expression frame fragment connection reaction system according to the volume ratio of the sgRNA expression frame fragment which is linearized and contains two target site DNA fragments to the pCAMBIA2301 plasmid which is linearized and contains a linker DNA fragment and a Cas9 expression frame, the T4 DNA ligase Buffer and the T4 DNA ligase are 6:20:3:1, connecting the sgRNA expression frame fragment which is linearized and contains two target site DNA fragments and the pCAMBIA2301 plasmid which is linearized and contains the linker DNA fragment and the Cas9 expression frame at the action of the T4 DNA ligase Buffer and the T4 DNA ligase at 4 ℃ overnight, transforming a connecting product into Escherichia coli 5 alpha competent cells, coating the cells on LB solid medium with 50 mu g/mL of kanamycin, culturing at 37 ℃ overnight, screening positive clones, and extracting expression vector plasmids edited by the BoB 101 gene.
6. The method according to claim 1, wherein the efficiency of the expression vector plasmid editing the BoMYB101 gene is 75-80%.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2021109424786 | 2021-08-17 | ||
CN202110942478 | 2021-08-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114317561A true CN114317561A (en) | 2022-04-12 |
CN114317561B CN114317561B (en) | 2024-01-09 |
Family
ID=81031544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210155687.0A Active CN114317561B (en) | 2021-08-17 | 2022-02-21 | CRISPR/Cas 9-based broccoli gene fixed-point editing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114317561B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023232429A1 (en) * | 2022-05-31 | 2023-12-07 | Bejo Zaden B.V. | Anthocyanin-free broccoli |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170114351A1 (en) * | 2014-06-12 | 2017-04-27 | King Abdullah University Of Science And Technology | TARGETED VIRAL-MEDIATED PLANT GENOME EDITING USING CRISPR /Cas9 |
US20200216853A1 (en) * | 2018-05-16 | 2020-07-09 | Huazhong Agricultural University | Method for rapidly and efficiently creating directed gene mutated non-transgenic plants and its applications |
CN111543307A (en) * | 2020-05-08 | 2020-08-18 | 南京农业大学 | Identification method for gene editing efficiency of Chinese cabbage or broccoli CRISPR-Cas9 gene editing system |
CN112063651A (en) * | 2020-08-20 | 2020-12-11 | 江苏省农业科学院 | Method for directionally editing common head cabbage gene by using CRISPR/Cas9 and application |
US20210147844A1 (en) * | 2018-07-04 | 2021-05-20 | Guangdong Sanjie Forage Biotechnology Co., Ltd | Method for Site-Specific Mutagenesis of Medicago Sativa Genes by Using CRISPR/Cas9 System |
-
2022
- 2022-02-21 CN CN202210155687.0A patent/CN114317561B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170114351A1 (en) * | 2014-06-12 | 2017-04-27 | King Abdullah University Of Science And Technology | TARGETED VIRAL-MEDIATED PLANT GENOME EDITING USING CRISPR /Cas9 |
US20200216853A1 (en) * | 2018-05-16 | 2020-07-09 | Huazhong Agricultural University | Method for rapidly and efficiently creating directed gene mutated non-transgenic plants and its applications |
US20210147844A1 (en) * | 2018-07-04 | 2021-05-20 | Guangdong Sanjie Forage Biotechnology Co., Ltd | Method for Site-Specific Mutagenesis of Medicago Sativa Genes by Using CRISPR/Cas9 System |
CN111543307A (en) * | 2020-05-08 | 2020-08-18 | 南京农业大学 | Identification method for gene editing efficiency of Chinese cabbage or broccoli CRISPR-Cas9 gene editing system |
CN112063651A (en) * | 2020-08-20 | 2020-12-11 | 江苏省农业科学院 | Method for directionally editing common head cabbage gene by using CRISPR/Cas9 and application |
Non-Patent Citations (2)
Title |
---|
ANDREW等: "MYBs Drive Novel Consumer Traits in Fruits and Vegetables", TRENDS IN PLANT SCIENCE, vol. 23, no. 8, pages 693 - 705, XP085429944, DOI: 10.1016/j.tplants.2018.06.001 * |
MIKHAELA NEEQUAYE等: "CRISPR-Cas9-Mediated Gene Editing of MYB28 Genes Impair Glucoraphanin Accumulation of Brassica oleracea in the Field", THE CRISPR JOURNAL, vol. 4, no. 3, pages 1 - 32 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023232429A1 (en) * | 2022-05-31 | 2023-12-07 | Bejo Zaden B.V. | Anthocyanin-free broccoli |
NL2032030B1 (en) * | 2022-05-31 | 2023-12-12 | Bejo Zaden Bv | Anthocyanin—free broccoli |
Also Published As
Publication number | Publication date |
---|---|
CN114317561B (en) | 2024-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109652440A (en) | Application of the VQRn-Cas9&PmCDA1&UGI base editing system in plant gene editor | |
CN107475256A (en) | It is a kind of based on more target sequence sgRNA expression vectors of endogenous tRNA systems of processing and its application in plant gene editor | |
KR102223568B1 (en) | Methods and compositions for integration of an exogenous sequence within the genome of plants | |
US10557146B2 (en) | Modified plants | |
CN107849581A (en) | Method and construct for the specific nucleic acid editor in plant | |
CN109593776B (en) | Method for quickly and efficiently obtaining non-transgenic directional gene mutant plant and application | |
CN106906214B (en) | Novel plant terminator sequences | |
CN113862283B (en) | Application of TGS1 gene in regulation and control of rice grain size and yield | |
CN114317561B (en) | CRISPR/Cas 9-based broccoli gene fixed-point editing method | |
Dunemann et al. | Using CRISPR/Cas9 to produce haploid inducers of carrot through targeted mutations of centromeric histone H3 (CENH3) | |
CN114317590B (en) | Method for mutating base C in plant genome into base T | |
CN116004712A (en) | Application of RH2 gene in regulation and control of cotton leaf stretching/shrinking character | |
CN117535311B (en) | Upland cotton GhCRP21 gene and encoding protein and application thereof | |
CN110628795B (en) | Cell enrichment technology using inactivated screening agent resistance gene as report system for A.G base substitution and application thereof | |
CN114317518B (en) | Application of SpRYn-CBE base editing system in plant genome base substitution | |
CN101818169B (en) | Method for improving content of protein and combined lysine in wheat seeds | |
CN112940092B (en) | Corn ZmbHLH124 protein and application of coding gene thereof in regulating and controlling plant drought tolerance | |
JP4912890B2 (en) | Method for producing plant cells with chromosomes lost | |
KR102149256B1 (en) | Composition for enhancing resistance to Xanthomonas oryzae pv. oryzae in rice plant | |
CN102417913A (en) | Method for improving salt tolerance of wheat | |
CN116987712A (en) | Taraxacum TmHY5 gene, expression protein and application thereof | |
CN101544988B (en) | Application of gene BC1L4 controlling synthesis of rice cellulose to genetic improvement of rice | |
Pilate et al. | Transgenic larch (Larix species) | |
CN104945491A (en) | Essential protein for chloroplast development, and gene and application thereof | |
JPS6054683A (en) | Novel dna and hybrid dna |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |